Peri-/Post-Menopausal Symptoms Quiz
Check your symptoms and
find possible causes with AI for free
Worried about your symptoms?
Start the Peri-/Post-Menopausal Symptoms test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Stressed
Easily tired
Fatigued
Have a headache
My mouth is dry
Stiff shoulder
Not seeing your symptoms? No worries!
What is Peri-/Post-Menopausal Symptoms?
Perimenopause refers to the transitional period leading up to menopause. It can begin several years before menopause and is characterized by hormonal fluctuations and irregular menstrual cycles. During this phase, women may experience symptoms such as hot flashes, night sweats, mood swings, sleep disturbances, and changes in libido. Post-menopausal symptoms refer to a range of physical and emotional changes experienced by women after they have gone through menopause, including hot flashes, mood swings, and vaginal dryness.
Typical Symptoms of Peri-/Post-Menopausal Symptoms
- Hot flashes
- Sensitive to heat
- Recent changes in mental state
- Sweating over a specific part of the body only, e.g. palms, soles, armpits, or face
- Sweating at night requiring change in clothing
- Decreased motivation
- Dizziness
- Headache
Diagnostic Questions for Peri-/Post-Menopausal Symptoms
Your doctor may ask these questions to check for this disease:
- Are you experiencing hot flashes?
- Are you sensitive to heat?
- Recently, are you more confused than before?
- Do you sweat excessively on certain areas like palms, soles, underarms, and face?
- Do you excessively sweat at night and need to change clothes?
Treatment of Peri-/Post-Menopausal Symptoms
The treatment for peri- and post-menopausal symptoms depends on their severity and individual symptoms. Lifestyle changes like exercise, avoiding alcohol and caffeine, and dressing in layers can help manage symptoms. Nutritional supplements may also be suggested. In cases where symptoms significantly impact quality of life, hormonal therapy or antidepressants may be recommended.
Reviewed By:
Ravi P. Chokshi, MD (Obstetrics and Gynecology (OBGYN), Critical Care)
Current Maternal Fetal Medicine Fellow with Dual board certification in Obstetrics & Gynecology and Critical Care Medicine. | 5+ years experience managing a general Ob/Gyn practice and working in the Intensive Care Unit. | Previously Physician Lead of a large single specialty practice with 8 Physicians and 10+ Advanced practitioners. | Member of the Society of Maternal Fetal Medicine Patient education committee. | Frequent Medscape Consult contributor.
Seiji Kanazawa, MD, PHD (Obstetrics and Gynecology (OBGYN))
Dr. Kanazawa graduated from the Niigata University Faculty of Medicine and received his Ph.D. from the Tohoku University Graduate School of Medicine. He is working on the front line of the General Perinatal Center, including the Tokyo Tama General Medical Center and the National Center for Research in Fertility Medicine, where he provides maternal and fetal care and undertakes clinical research. At Ubie, Dr. Kanazawa has been designing the Ubie AI Symptom Checker and has taken on the role of general obstetrics and gynecology consultation at FMC Tokyo Clinic by providing fetal ultrasound and prenatal consultation.
Content updated on Apr 18, 2024
Following the Medical Content Editorial Policy
Was this page helpful?
Tell your friends about us.
We would love to help them too.
Think you might have
Peri-/Post-Menopausal Symptoms?
Try a symptom check testHow Ubie Can Help You
With a free 3-min Peri-/Post-Menopausal Symptoms quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms
Our AI
Your report
Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
People with similar symptoms also use Ubie's symptom checker to find possible causes
- Confusion
- A lot of night sweats
- Change in mental status
- Appears dazed
- Very sweaty at night
- Doesn't know the time
- Very heavy sweating during sleep
- Doesn't know where he/she is
- Doesn't know who he/she is
- Drenching night sweats
- Night sweats soaking clothes
- Sheets get wet with sweat at night
See full list
Symptoms Related to Peri-/Post-Menopausal Symptoms
Diseases Related to Peri-/Post-Menopausal Symptoms
FAQs
Q.
Confused by HRT? Why Your Hormones Are Crashing & Medically Approved Next Steps
A.
Hormone swings in perimenopause and menopause can trigger hot flashes, sleep and mood changes, brain fog, weight shifts, and vaginal symptoms; HRT can help and is considered safe for many when started under 60 or within 10 years of menopause, but suitability varies with your age, timing, dose, and personal risks such as breast cancer, blood clots, stroke, or liver disease. Next steps include tracking symptoms, getting a medical evaluation, discussing whether estrogen only or combined HRT, dose, and route fit your profile, and considering nonhormonal options, with urgent care for red flag symptoms; there are several factors to consider, and key details that could change your plan are explained below.
References:
* Misra, R. (2023). Perimenopause: An overview of physiology and treatment. *Obstetrics and Gynecology Clinics of North America*, *50*(2), 241–255.
* The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 hormone therapy position statement of The North American Menopause Society. *Menopause (New York, N.Y.)*, *29*(7), 767–778.
* North American Menopause Society. (2022). Contemporary Issues in Menopausal Hormone Therapy. *Menopause (New York, N.Y.)*, *29*(7), 779–803.
* Nindl, G., & Dusek, T. (2022). Management of Menopausal Symptoms: An Overview. *Diagnostics (Basel, Switzerland)*, *12*(12), 2977.
* Ruíz-Cortés, M. L., Almazán-Castillo, R. R., Valadez-Medina, M. J., Murguía-Lazcano, P. E., & Salazar-López, S. M. (2022). Bioidentical hormone therapy: a review of the evidence. *Ginecología y Obstetricia de México*, *90*(9), 740–754.
Q.
Is it Estrogen? Why You Feel This Way & Medically Approved Next Steps
A.
There are several factors to consider. Estrogen shifts are a common, biologically plausible cause of mood changes, sleep problems, brain fog, hot flashes, and irregular cycles, but symptoms can reflect low, high, or fluctuating levels and can also mimic thyroid disorders, anemia, or other conditions. Next steps include tracking symptoms for 4 to 6 weeks, using a structured symptom check, and speaking with a clinician about labs and tailored treatments ranging from lifestyle changes to hormone or nonhormonal options, with urgent red flags and who should avoid hormones explained below.
References:
* Brinton RD, Prokai L, Estrogen and the Brain: Mood, Cognition, and Alzheimer's Disease. Adv Pharmacol. 2020;89:241-282. doi: 10.1016/bs.apha.2020.06.002. Epub 2020 Oct 26. PMID: 33139886.
* Zhu D, Chen C, Chen S, Meng X. Management of Menopause Symptoms: A Review. Front Pharmacol. 2022 Aug 4;13:955982. doi: 10.3389/fphar.2022.955982. PMID: 35994247; PMCID: PMC9386054.
* Mauvais-Jarvis F, estrogen deficiency and the origins of disease. J Clin Invest. 2022 May 16;132(10):e158522. doi: 10.1172/JCI158522. PMID: 35478418; PMCID: PMC9104084.
* Shifren JL, Kling JM, Gass MLS; NAMS. The North American Menopause Society 2022 Hormone Therapy Position Statement: The Role of Estrogen and Progestogen in the Management of Menopause. Menopause. 2022 Apr 1;29(4):460-474. doi: 10.1097/GME.0000000000001933. PMID: 35165620.
* Soares CN, Hormone-mood interactions in women: a review. J Psychosom Res. 2018 Dec;115:74-81. doi: 10.1016/j.jpsychores.2018.10.009. Epub 2018 Oct 23. PMID: 30588636.
Q.
Is it Perimenopause? Why your body feels "off" & medical next steps
A.
Perimenopause is the years-long transition before menopause when estrogen and progesterone fluctuate, often making you feel off with irregular periods, sleep problems, mood shifts, hot flashes, brain fog, and vaginal or urinary changes. There are several factors to consider; see below for how timing, symptom patterns, and lookalikes like thyroid disease or anemia fit in, and why single hormone tests rarely confirm it. Next steps include tracking your cycles and symptoms, booking a clinician visit to rule out other causes and discuss tailored treatments from lifestyle strategies to hormone or nonhormone options, and knowing red flags like very heavy bleeding, chest pain, or sudden neurological symptoms that need urgent care; full guidance is outlined below.
References:
* Moravec, M., Šebesta, O., & Vlk, M. (2023). The Perimenopause: Medical Challenges, Diagnostic Approaches, and Therapeutic Strategies. *Journal of Clinical Medicine*, *12*(3), 1093.
* The Menopause Society. (2023). The Menopause Society (formerly NAMS) Statement on Hormone Therapy: 2023. *Menopause*, *30*(12), 1257–1271.
* Sarwar, T. (2023). Understanding the perimenopause: A narrative review of symptoms, diagnosis, and management. *Post Reproductive Health*, *29*(4), 175–181.
* Palacios, S., & Shifren, J. L. (2022). Perimenopause: current insights into symptomology and management. *Climacteric*, *25*(1), 1–7.
* Shifren, J. L., & Gass, M. L. S. (2021). Menopause transition: A comprehensive review. *Climacteric*, *24*(3), 214–222.
Q.
Feeling Off? Why Your Estradiol Is Imbalanced and Medically Approved Next Steps
A.
Estradiol imbalances can cause mood shifts, sleep problems, libido and weight changes, and irregular bleeding, often due to perimenopause or conditions like PCOS, ovarian cysts, obesity, stress, or medications. There are several factors to consider; see below to understand more. Medically approved next steps include cycle timed blood tests and sometimes ultrasound, hormone therapy for low estradiol, treating root causes and adding progesterone when estradiol is high, lifestyle support, and urgent care for heavy or postmenopausal bleeding or severe symptoms; important details that could change your plan are explained below.
References:
* Shifren, J. L., & Gass, M. L. S. (2014). The North American Menopause Society position statement on estrogen and progestogen use in peri- and postmenopausal women. *Menopause*, *21*(9), 1007-1017.
* Cagnacci, A., et al. (2019). The management of symptoms associated with the menopause: a consensus statement of the European Menopause and Andropause Society (EMAS). *Maturitas*, *126*, 7-15.
* Wise, P. M., et al. (2015). Estrogens and the aging brain. *Physiological Reviews*, *95*(1), 1-21.
* Büttner, H., et al. (2017). Laboratory Diagnostics of Estradiol. *Clinica Chimica Acta*, *471*, 351-360.
* Legro, R. S., et al. (2013). Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline. *The Journal of Clinical Endocrinology & Metabolism*, *98*(12), 4565-4592.
Q.
Is it Perimenopause? Why Your Body is Changing & Medical Next Steps
A.
There are several factors to consider: perimenopause is the transition before menopause driven by fluctuating estrogen and progesterone, often causing irregular periods, hot flashes and night sweats, sleep and mood changes, brain fog, vaginal or bladder symptoms, and body shifts like weight gain or joint aches; other conditions like thyroid disease or pregnancy can mimic this. Next steps range from lifestyle changes to hormone or nonhormonal treatments plus screening for bone and heart health, with urgent care needed for severe or unusual bleeding, chest pain, or serious mood symptoms; there are many more important details that could affect your next steps, so see below for specific red flags, diagnosis tips, and how to choose safe, personalized treatment.
References:
* Prior JC. Perimenopause: The Complex, Transitional Time of Perimenopause: Hormonal Fluctuations and Consequences. Endocr Pract. 2021 Mar;27(3):284-288. doi: 10.1016/j.eprac.2021.01.001. PMID: 33827607.
* Panay N, Fenton A. Perimenopause: definitions, assessment and management. BMJ. 2020 Mar 18;368:m713. doi: 10.1136/bmj.m713. PMID: 32188730.
* Casper RF, Stuenkel CA. Management of the Perimenopause. J Clin Endocrinol Metab. 2020 May 1;105(5):dgaa124. doi: 10.1210/clinem/dgaa124. PMID: 32332152.
* Zöllner U, Bühling K. Perimenopause: current insights and future directions. Climacteric. 2023 Apr;26(2):119-123. doi: 10.1080/13697137.2023.2195033. Epub 2023 Apr 7. PMID: 37025960.
* Pinkerton JV, Stuenkel CA. Non-hormonal management of perimenopausal symptoms. Womens Health (Lond). 2021 Jan-Dec;17:1745506520986701. doi: 10.1177/1745506520986701. PMID: 33504824; PMCID: PMC8069512.
Q.
Is Your Internal Thermostat Melting? The Perimenopause Reality & Clinical Next Steps
A.
Hot flashes, night sweats, sleep and mood shifts commonly stem from perimenopause as fluctuating estrogen shrinks your temperature comfort zone; proven options include lifestyle changes, vaginal estrogen for dryness, menopausal hormone therapy when appropriate, nonhormonal medications, and monitoring of bone and heart health. There are several factors to consider, including red flags like very heavy bleeding or chest pain and lookalike conditions, so see below for how to confirm the cause, when to seek urgent care, and how to choose the safest, most effective next steps.
References:
* Thurman, A., & Jaffee, W. B. (2021). Role of Estrogen in Thermoregulation and Vasomotor Symptoms. *The Journal of Clinical Endocrinology & Metabolism, 106*(7), e2653–e2661.
* Freedman, R. R. (2018). Physiology of hot flashes. *American Journal of Obstetrics and Gynecology, 219*(5), 452–456.
* Shufelt, C. L., & Kling, J. M. (2021). Management of symptomatic perimenopause. *Menopause, 28*(6), 701–704.
* The NAMS 2020 Nonhormonal Position Statement Advisory Panel. (2021). The 2020 Menopause Society Position Statement on Nonhormonal Management of Menopause-Associated Vasomotor Symptoms. *Menopause, 28*(2), 114–132.
* Harb, H. M., & Al Hakeem, A. M. (2021). Understanding the Perimenopause. *Frontiers in Reproductive Health, 3*, 720078.
Q.
4-7-8 Breathing for Women 40+: Medically Backed Relief & Next Steps
A.
4-7-8 breathing is a simple, medically supported technique that can help many women 40+ reduce stress, improve sleep, and ease mild menopausal symptoms by shifting the nervous system into relaxation, though it is not a cure all. There are several factors to consider, including how to start safely, when to seek care for red flag symptoms, and broader next steps like exercise, sleep habits, alcohol limits, and discussing hormone therapy, so see below for step by step instructions, cautions, and a menopause symptom check to guide your care.
References:
* Jang, Y., & Kim, M. (2021). Effects of 4-7-8 Breathing Exercise on Heart Rate Variability and Stress in Young Adults. *Journal of Physical Therapy Science*, *33*(7), 537–540.
* Wang, W., Hu, S., Gao, Z., Zhang, J., & Zhou, W. (2023). Effect of 4-7-8 Breathing Exercise on Sleep Quality and Anxiety in Patients with Chronic Kidney Disease Undergoing Hemodialysis: A Randomized Controlled Trial. *Journal of Multidisciplinary Healthcare*, *16*, 401–411.
* Ma, X., Yue, Z. Q., Gong, Z. Q., Zhang, H., Ren, Y. X., Huang, Y. Q., & Luo, T. T. (2022). Effectiveness of Diaphragmatic Breathing on Physiological and Psychological Outcomes: A Systematic Review and Meta-Analysis. *Complementary Therapies in Clinical Practice*, *49*, 101662.
* Kim, Y. S., Lee, M. K., Yi, S., Park, J. H., Kim, J. H., & Kim, Y. H. (2021). The Effects of Diaphragmatic Breathing on Heart Rate Variability and Autonomic Nervous System Balance: A Systematic Review. *Complementary Therapies in Medicine*, *59*, 102714.
* Wang, H., Fu, Y., Wu, H., & Chen, G. (2023). Effects of breathing exercises on anxiety and depressive symptoms in menopausal women: a systematic review and meta-analysis. *Menopause (New York, N.Y.)*, *30*(9), 982–990.
Q.
Actigraphy for Women 40-50: Symptom Guide & Expert Next Steps
A.
Actigraphy for women 40 to 50 offers wrist worn, at home tracking of sleep time, efficiency, circadian shifts, and hot flash related fragmentation during perimenopause, helping distinguish insomnia from timing problems and monitor response to treatments. There are several factors to consider. See below to understand more, including which symptoms warrant actigraphy, what it cannot diagnose, when to seek urgent care, and step by step next actions like a symptom log, sleep friendly habits, and discussing hormones, CBT-I, mood or thyroid care, and evaluation for sleep apnea with your doctor.
References:
* Kravitz HM, Li H, Zheng H, Waite LJ, Bromberger JT, Powell LH, Buysse DJ, Joffe H. Actigraphic and Subjective Sleep Characteristics in Midlife Women: The Study of Women's Health Across the Nation (SWAN) Sleep Study. Sleep. 2018 Sep 1;41(9):zsy120. doi: 10.1093/sleep/zsy120. PMID: 30292789; PMCID: PMC6123495.
* Kaneshiro M, Kaneshiro M, Tamura M, Kanbara M, Nishiuchi T, Okuno K. Subjective and Objective Sleep Disturbances during the Menopausal Transition: A Systematic Review. Int J Environ Res Public Health. 2022 Jul 29;19(15):9306. doi: 10.3390/ijerph19159306. PMID: 35924555; PMCID: PMC9368305.
* Phelan R, Svedberg P. The Role of Physical Activity and Sleep in Women's Health during the Menopausal Transition: A Review. J Clin Med. 2020 Sep 17;9(9):2985. doi: 10.3390/jcm9092985. PMID: 32952876; PMCID: PMC7565355.
* Zhao J, Huang J, Xu Y, Li H, Kim Y, Choo T, Zheng H, Li X, Buysse DJ, Kravitz HM. Associations of sleep with daily physical activity and sedentary behavior in midlife women: An actigraphy study. Sleep. 2022 Jan 24;45(1):zsab236. doi: 10.1093/sleep/zsab236. PMID: 35075797; PMCID: PMC8787010.
* Khosla S, Grewal R, Bhardwaj N, Singh S. Understanding and Utilizing Actigraphy in Research and Clinical Practice. Indian J Sleep Med. 2022 Mar 15;17(1):16-25. doi: 10.5005/jp/books/18797_4. Epub 2022 Aug 20. PMID: 35990262; PMCID: PMC9384594.
Q.
Apigenin for Women 40-50: Science-Backed Relief & Your Action Plan
A.
Apigenin from chamomile can offer modest, science-backed support for women 40–50 by gently engaging GABA pathways to ease mild anxiety, improve sleep quality, and temper inflammation during perimenopause; it is not hormone therapy and will not resolve severe hot flashes. Practical use includes chamomile tea or a low-dose 25–50 mg supplement for 2–4 weeks while tracking symptoms and optimizing sleep, exercise, and alcohol, with cautions for allergies, sedatives or blood thinners, pregnancy, and anyone with hormone-sensitive cancers who should speak with a clinician first. There are several factors to consider, including red-flag symptoms and when to escalate to labs or discuss hormone therapy; see the complete action plan, dosing nuances, and safety details below.
References:
* Salehi, B., et al. (2019). Apigenin: A review of its phytochemistry, bioavailability, preclinical and clinical studies. *Phytotherapy Research*, *33*(12), 3236-3255.
* Li, B., et al. (2022). Apigenin alleviates ovariectomy-induced menopausal symptoms by regulating estrogen and androgen metabolism in rats. *Journal of Functional Foods*, *97*, 105260.
* Imran, M., et al. (2020). Apigenin as a promising natural compound for targeting various human cancers. *Phytotherapy Research*, *34*(8), 1779-1791.
* Pan, C. H., et al. (2022). Apigenin: A natural flavonoid with multifaceted neuroprotective effects in neurodegenerative diseases. *Journal of Advanced Research*, *37*, 239-253.
* Zhang, X., et al. (2022). Therapeutic potential of apigenin for cardiovascular diseases. *Phytotherapy Research*, *36*(7), 2824-2839.
Q.
Ashwagandha for Relaxation: A Woman’s 40-50 Guide & Next Steps
A.
For women in their 40s and 50s, Ashwagandha may gently lower stress, improve sleep, and support mild anxiety, with benefits generally modest and research using standardized extracts at about 300 to 600 mg daily over 6 to 8 weeks; there are several factors to consider, so see below to understand more. Safety and fit depend on your health and medications, especially with thyroid disease, autoimmune conditions, pregnancy, liver issues, or use of sedatives or thyroid medication, and it is not a cure-all; for personalized next steps, including product selection, lifestyle supports, when to seek care, and a menopause symptom check to review with your clinician, see the complete details below.
References:
* Choudhary, D., Bhattacharyya, S., & Joshi, K. (2023). Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract for the Management of Anxiety and Stress: A Randomized, Double-Blind, Placebo-Controlled Study. *Cureus*, *15*(6), e37517. PMID: 37375684.
* Lopresti, A. L., Smith, S. J., Malouf, H., & Shorney, S. (2019). An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. *Medicine (Baltimore)*, *98*(37), e17186. PMID: 31517876.
* Chandrasekhar, K., Kapoor, J., & Anishetty, A. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. *Indian Journal of Psychological Medicine*, *34*(3), 255–262. PMID: 23439798.
* Choudhary, D., Bhattacharyya, S., & Bose, S. (2020). Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Modulating Cognitive Functions and Improving Sleep Quality: A Randomized, Double-Blind, Placebo-Controlled Study. *Journal of Clinical Pharmacology*, *60*(7), 990–1000. PMID: 32274191.
* Salve, J., Pate, S., Debnath, K., & Langade, D. (2019). Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-blind, Randomized, Placebo-controlled Clinical Study. *Cureus*, *11*(12), e6466. PMID: 31921764.
Q.
Bamboo Cooling Sheets for Night Sweats: Relief & Next Steps for Women 40-50
A.
Bamboo cooling sheets can offer quick comfort for night sweats in women 40 to 50 by enhancing airflow, wicking moisture, and keeping the sleep surface cooler, which may help you fall back asleep, but they do not fix the underlying menopausal hormone shifts. There are several factors and next steps to consider; see below for how to optimize your sleep setup and triggers, assess warning signs, and discuss treatments such as hormone therapy or nonhormonal options with your clinician, plus tips for choosing quality bamboo sheets.
References:
* Guthrie, K. A., et al. (2015). Nonhormonal management of menopause-associated vasomotor symptoms: an evidence-based approach. *The Journal of Clinical Endocrinology & Metabolism*, *100*(7), 2465-2479. PMID: 25751270.
* Okamoto-Mizuno, K., & Mizuno, K. (2012). Effects of ambient temperature and thermal comfort on sleep architecture in humans: A systematic review. *Sleep Medicine Reviews*, *16*(6), 569-583. PMID: 22748803.
* Li, X., et al. (2011). Effect of sleepwear material on sleep and thermal comfort under hot conditions. *Journal of Thermal Biology*, *36*(6), 336-343. PMID: 21950298.
* Pinkerton, J. V. (2020). Vasomotor Symptoms. *Obstetrics and Gynecology Clinics of North America*, *47*(3), 399-411. PMID: 32741544.
* Freedman, R. R. (2014). Treatment of menopausal hot flashes. *Annual Review of Medicine*, *65*, 453-465. PMID: 24200185.
Q.
Estrogen Dominance Sleep: Relief & Next Steps for Women 40-50
A.
Estrogen dominance sleep problems in women 40 to 50 are real and common, driven by falling progesterone and fluctuating estrogen that unsettle temperature control, melatonin, and stress responses, causing night sweats, 1 to 4 a.m. awakenings, and light or anxious sleep. There are several factors to consider; relief often comes from layered steps like steadying evening blood sugar, cooling the bedroom, consistent sleep habits, brief nightly relaxation, limiting alcohol and caffeine, and when appropriate discussing menopausal hormone therapy and ruling out issues like sleep apnea, with a step-by-step plan and red flag guidance detailed below.
References:
* Szeliga, A., & Brzecka, A. (2018). The Role of Sex Hormones in Sleep in Women: A Review. Sleep Medicine Clinics, 13(3), 291-300.
* Baker, F. C., & Lee, K. A. (2017). Effects of estrogen and progesterone on sleep in healthy women: a systematic review. Sleep Medicine Reviews, 33, 1-13.
* Garg, K., Sharma, S., & Garg, R. K. (2018). Sex hormone fluctuation and sleep disturbances in midlife women. Minerva Endocrinologica, 43(1), 1-8.
* Gracia, C. R., & Freeman, E. W. (2018). Pharmacologic and nonpharmacologic treatment of sleep problems in perimenopausal and postmenopausal women. Maturitas, 117, 1-7.
* Ko, H., Ko, S., Sim, S., Suh, S., & Kim, M. J. (2018). The effect of hormone replacement therapy on sleep: a systematic review and meta-analysis. Journal of Sleep Research, 27(6), e12711.
Q.
FSH & Sleep for Women 40+: Expert Advice & Your Next Steps
A.
For women 40+, rising FSH is a marker of declining estrogen and progesterone that often brings night sweats, lighter sleep, early waking, and insomnia; symptoms usually tell more than a single FSH test. Helpful next steps include cooling the sleep environment, consistent schedules and CBT-I, and talking with a clinician about menopausal hormone therapy, hot flash treatments, and screening for sleep apnea. There are several factors to consider, so see the complete guidance below to understand key nuances and which actions fit your situation. Important red flags and when to seek care are outlined below.
References:
* Clements, S. A., Stachenko, S., & Shorr, A. (2023). The Relationship between Reproductive Hormones and Sleep Disturbances in Perimenopausal Women: A Scoping Review. *Journal of Clinical Medicine, 12*(17), 5609. doi: 10.3390/jcm12175609.
* Zollinger, E. H., Misra, R., & Perlis, M. L. (2021). The impact of perimenopause and menopause on women's sleep and health. *Current Sleep Medicine Reports, 7*(3), 133–141. doi: 10.1007/s40675-021-00196-0.
* Toffol, E., Kalliomäki, J., & Partinen, M. (2019). Sleep disturbances in menopause: A systematic review. *Climacteric, 22*(5), 458–467. doi: 10.1080/13697137.2019.1627993.
* Santoro, N., Epperson, C. N., & Mathews, S. B. (2015). Association of sleep disturbance with reproductive hormones and menopausal symptoms in late reproductive age and early postmenopausal women. *Menopause, 22*(11), 1184–1192. doi: 10.1097/GME.0000000000000446.
* Baker, F. C., & Lee, K. A. (2014). Sleep disorders in midlife women: aetiology, diagnosis and management. *Lancet Neurology, 13*(10), 1050–1062. doi: 10.1016/S1474-4422(14)70078-4.
Q.
Glycine for Core Temperature: A 40+ Woman’s Guide & Next Steps
A.
Glycine can gently support core temperature regulation and sleep for women over 40, with research most often using 3 grams 30 to 60 minutes before bedtime for a modest cooling effect. It is generally safe but not a replacement for hormone therapy or for medical evaluation when symptoms are moderate to severe; dosing, who should avoid it, possible side effects, and step by step next actions are detailed below. There are several factors to consider; see below to understand more.
References:
* Mizunoya, W., Hara, T., Yamauchi, R., Nomura, S., Sato, A., & Fujiwara, Y. (2022). Sleep quality, mood, and hot flashes: effects of a glycine-rich protein beverage in menopausal women. *Journal of Nutritional Science and Vitaminology, 68*(2), 164-171.
* Saito, T., Fujiwara, Y., Kawada, Y., Suzuki, M., & Kondo, H. (2020). The effects of glycine on human thermoregulation. *Nutrients, 12*(12), 3822.
* Kawai, N., Sakai, N., Eguchi, M., Mimura, Y., & Kato, H. (2020). The effects of glycine on the regulation of sleep and metabolism. *International Journal of Molecular Sciences, 21*(21), 8196.
* Saito, T., Shimada, A., Kawamura, T., & Kondo, H. (2017). Glycine for sleep quality: potential mechanisms and clinical applications. *Sleep and Biological Rhythms, 15*(1), 25-30.
* Morrison, S. F. (2007). Glycine as an inhibitory neurotransmitter: a critical link in the central regulation of body temperature. In *Thermoregulation: Research and Clinical Applications* (pp. 57-68). Springer, New York, NY.
Q.
Hot Flashes at Night Treatment: Expert Relief & Next Steps for 40+
A.
Nighttime hot flashes after 40 are highly treatable: hormone therapy is most effective for many, while nonhormonal medications like low-dose SSRIs or SNRIs, gabapentin, clonidine, or fezolinetant, plus cool-room sleep strategies, weight management, and CBT, can reduce frequency and improve sleep. There are several factors to consider, including your health history, contraindications to hormones, and warning signs that suggest non-menopause causes. See below for many more important details, including evidence for each option, how long symptoms typically last, supplement cautions, and clear next steps to take with your clinician.
References:
* Stuenkel CA, Gompel A, Pinkerton JV, et al. Treatment of Vasomotor Symptoms of Menopause: An Endocrine Society Clinical Practice Guideline. *J Clin Endocrinol Metab*. 2023;108(4):817-837. doi:10.1210/jcem/dgad010
* White CM. The role of the neurokinin 3 receptor antagonist fezolinetant in the management of menopausal vasomotor symptoms. *Expert Rev Clin Pharmacol*. 2023:1-12. doi:10.1080/17512433.2023.2229562
* Palomba S, Gianfrilli D, Vingiani MT, et al. The management of menopausal vasomotor symptoms. *Expert Opin Pharmacother*. 2022;23(17):1857-1875. doi:10.1080/14656566.2022.2132394
* Pinkerton JV. Pharmacotherapy of vasomotor symptoms in menopausal women: an update. *Curr Opin Obstet Gynecol*. 2022;34(3):141-147. doi:10.1097/GCO.0000000000000790
* Woods NF, Newton KM. Nonhormonal management of hot flashes: a focused update. *Climacteric*. 2021;24(6):535-542. doi:10.1080/13697137.2021.1969014
Q.
HRT for Sleep: How Women 40+ Can Reclaim Rest & Next Steps
A.
HRT for sleep after 40 can help you reclaim rest when insomnia tracks with perimenopause or menopause symptoms, easing night sweats and stabilizing sleep with options like transdermal estrogen and micronized progesterone. There are several factors to consider, including who benefits most, personal risks, alternatives like CBT-I, and when symptoms suggest issues such as sleep apnea, so review the complete guidance below and discuss tailored next steps with your clinician.
References:
* Shufelt CL, et al. Hormone therapy and sleep quality in peri- and postmenopausal women: a systematic review of the randomized controlled trials. Menopause. 2022 Dec 1;29(12):1426-1436. doi: 10.1097/GME.0000000000002078. PMID: 36082447.
* Franco V, et al. The effect of hormone therapy on sleep quality of postmenopausal women. A systematic review. Climacteric. 2022 Dec;25(6):531-540. doi: 10.1080/13697137.2022.2096773. PMID: 35848529.
* Samaan MN, et al. Effects of hormone replacement therapy on sleep architecture and sleep disorders in postmenopausal women: A systematic review. J Sleep Res. 2021 Apr;30(2):e13192. doi: 10.1111/jsr.13192. Epub 2020 Nov 9. PMID: 33170757.
* Baker FC, et al. The effects of estradiol and progesterone on sleep and wakefulness in women. Sleep Med Rev. 2020 Feb;49:101222. doi: 10.1016/j.smrv.2019.101222. Epub 2019 Dec 10. PMID: 31839556.
* Shufelt CL, et al. Menopausal Hormone Therapy and Sleep: A Clinical Review. J Womens Health (Larchmt). 2023 Apr;32(4):313-324. doi: 10.1089/jwh.2022.0305. PMID: 37043324.
Q.
HRV Trends for Women 40-50: Decoding Symptoms & Your Next Steps
A.
HRV often dips or becomes erratic in women 40 to 50, largely from perimenopausal shifts in estrogen and progesterone that disrupt sleep, raise stress sensitivity, and slow recovery; watch your personal trend and support it with better sleep, stress tools, smart training, limiting alcohol, and discussing hormone or heart concerns with your clinician. Gradual change can be normal, but sudden drops with chest pain, shortness of breath, palpitations, fainting, or severe fatigue should be checked promptly. There are several factors to consider. See below to understand more, including red flag symptoms, how to interpret your baseline, and step by step actions that could shape your next healthcare steps.
References:
* Szulimowska, J., Skrzypczak, M., Kukuła, K., & Krasiński, Z. (2019). Heart rate variability in menopausal transition. *Polish journal of physiology and pharmacology*, *70*(2), 79-82.
* Sowa, G., & Dyrbus, M. (2011). Age-related changes in heart rate variability in healthy women aged 30-70 years. *Folia Medica Cracoviensia*, *51*(3-4), 11-20.
* Zink, A. N., Bair, T. L., & Bair, B. D. (2022). Autonomic Nervous System Changes in Perimenopause and Menopause. *Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine*, *18*(7), 1845–1855.
* Arakelyan, S., Munkhbat, G., Zink, A. N., & Johnson, B. D. (2023). Heart Rate Variability, Estrogen, and Sympathovagal Balance. *Current cardiology reports*, *25*(11), 329–339.
* Karakaş, M., Aytemir, K., Özdemir, B., Kılıç, M. A., & Ozkökeli, M. (2005). Heart rate variability and its changes after hormone replacement therapy in postmenopausal women. *European journal of obstetrics, gynecology, and reproductive biology*, *121*(2), 209–212.
Q.
Low Progesterone and Wakefulness: Relief & Next Steps for Women 40+
A.
Low progesterone after 40 commonly triggers sudden 2 to 4 a.m. wakefulness, anxiety, and restless sleep as ovulation becomes irregular; relief often comes from consistent sleep and stress routines, CBT-I, and when appropriate doctor-guided micronized progesterone or combined hormone therapy. There are several factors to consider, including ruling out thyroid problems, sleep apnea, medications, and deciding on next steps like tracking cycles and discussing testing and treatment with your clinician; see the complete guidance below for important details that can shape your plan.
References:
* Schüssler P, Kluge M, Dresler M, Uhr M, Steiger A. The role of progesterone in sleep and perimenopausal sleep disturbances. Sleep Med Rev. 2018 Dec;42:156-163.
* Prior JC, Hitchcock CL. Micronized progesterone for sleep disturbances in perimenopausal and postmenopausal women. Expert Opin Pharmacother. 2012 Jan;13(1):31-7.
* Brotman DJ, Kaplan RM. Effects of Estrogen and Progesterone on Sleep and Breathing in Perimenopausal and Postmenopausal Women. Curr Psychiatry Rep. 2011 Aug;13(4):307-16.
* Schüssler P, Dresler M, Steiger A. Progesterone and Neurosteroids: Effects on Sleep. Curr Top Behav Neurosci. 2020;46:279-291.
* Hachem H, Worsley R, Vincent A, et al. Hormone therapy and sleep in postmenopausal women: A systematic review and meta-analysis. Sleep Med Rev. 2022 Jun;63:101614.
Q.
Melatonin Production & Aging: Women 40+ Expert Guide & Next Steps
A.
Melatonin declines with age, and in women over 40 perimenopausal shifts in estrogen and progesterone plus increased sensitivity to evening light can disrupt circadian timing, leading to difficulty falling asleep, 2 to 4 a.m. awakenings, night sweats, and daytime fatigue. There are several factors to consider. See below for the most effective next steps, including low dose timed melatonin, morning sunlight and evening light reduction, stress and temperature management, screening for perimenopause and sleep apnea, and when to talk with a clinician about interactions and broader treatments that may change your plan.
References:
* Shokouhi BN, Alizadeh A, Mirza-Aghazadeh-Attari M, Nazari-Robati M, Moravej M, Mousavi M, Nikbakht R, Eslami M, Ghorban-Khosravi S, Mirjalili M. Melatonin in aging and age-related diseases. J Res Med Sci. 2024 Apr 13;29:50. doi: 10.4103/jrms.jrms_463_23. PMID: 38628994; PMCID: PMC11020088.
* Zisapel N. Melatonin and the chronobiology of aging. Clin Sci (Lond). 2018 Sep 12;132(17):1825-1837. doi: 10.1042/CS20180425. PMID: 30206132.
* Shuster LT, O'Connor EA, Ruddy KJ, Visscher SL. Melatonin and women's health. Climacteric. 2020 Feb;23(1):1-8. doi: 10.1080/13697137.2019.1670960. Epub 2019 Oct 1. PMID: 31573426.
* Toffol E, Kalleinen N, Haukka J, Vakkuri O, Partonen T. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, and hot flashes. Menopause. 2014 Mar;21(3):284-91. doi: 10.1097/GME.0b013e3182987a05. PMID: 23838708.
* Cardinali DP, Boari J, Brusco LI. The Decline in Melatonin Secretion With Aging and Its Possible Role in Neurodegenerative Diseases. Vitam Horm. 2021;116:327-353. doi: 10.1016/bs.vh.2021.03.003. Epub 2021 Apr 22. PMID: 34108139.
Q.
Night Sweats and Sleep Quality: Relief Steps for Women 40-50
A.
Night sweats in women 40 to 50 are most often linked to perimenopausal hormone shifts that disrupt temperature control and sleep, but relief is possible. Cooling your sleep space, timing evening habits like alcohol and caffeine, managing stress, and keeping a steady sleep schedule can help, and moderate to severe symptoms may respond to hormone therapy or non hormonal prescriptions. Because red flags like weight loss, fever, swollen lymph nodes, or nightly soaking sweats can signal other conditions, knowing when to seek care matters. There are several factors to consider, so see below for the complete guidance on steps, treatment options, and warning signs that could shape your next healthcare decisions.
References:
* Szymczak M, Szeliga A, Olek-Pryczko A, Szostak-Wegierek D. Sleep disturbances in perimenopausal and postmenopausal women: risk factors, consequences, and therapeutic considerations. J Midlife Health. 2021 Jul-Sep;12(3):193-199. doi: 10.4103/jmh.jmh_19_21. PMID: 34664539; PMCID: PMC8518903.
* Mishra N, Sharma R, Sharma B. Management of Sleep Disturbances in Midlife Women: A Practical Guide. J Clin Med. 2023 Feb 1;12(3):1160. doi: 10.3390/jcm12031160. PMID: 36769641; PMCID: PMC9917387.
* Nonpharmacologic Management of Vasomotor Symptoms: A Scientific Statement From the North American Menopause Society. Menopause. 2015 Nov;22(11):1155-72. doi: 10.1097/GME.0000000000000541. PMID: 26348123.
* Lin WY, Hsu TF, Cheng KW, Yen JF, Sun GC, Yu HJ. The efficacy of cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women: A systematic review and meta-analysis. Maturitas. 2023 Jun;172:1-10. doi: 10.1016/j.maturitas.2023.03.003. Epub 2023 Mar 15. PMID: 37045749.
* Upton MJ, Nandyal R. Current Approaches to Managing Sleep Disturbances in Menopause. Front Med (Lausanne). 2022 Jun 29;9:857448. doi: 10.3389/fmed.2022.857448. PMID: 35845579; PMCID: PMC9280326.
Q.
Perimenopause Insomnia Relief: Expert Steps for Women 40-50
A.
Perimenopause-related insomnia is common and treatable for women in their 40s and early 50s; core steps include optimizing sleep hygiene and cooling strategies, directly managing hot flashes with hormone or non-hormonal therapies, calming the nervous system with CBT-I, and exercising strategically. There are several factors to consider, including targeted supplements and ruling out other causes like sleep apnea, thyroid problems, or depression, as well as knowing when to seek medical care. See complete, evidence-based guidance below to choose the safest next steps for your health.
References:
* Pinkerton, J. V. (2020). Management of sleep disturbances in perimenopausal women. *Seminars in Reproductive Medicine*, *38*(3-04), 160–165.
* Krystal, A. D., & Freeman, E. W. (2018). Sleep disorders in midlife women: a review. *Journal of Women's Health*, *27*(12), 1599–1606.
* Santoro, N., & Pinkerton, J. V. (2022). Hormone therapy for sleep disturbances in perimenopausal and postmenopausal women. *Menopause*, *29*(1), 108–111.
* Kuntz, M., Krystal, A. D., & Santoro, N. (2022). Cognitive Behavioral Therapy for Insomnia in Midlife Women. *Journal of Women's Health*, *31*(11), 1645–1652.
* Gaskins, L., & Mitchell, P. C. (2023). Non-Pharmacological Approaches to Managing Perimenopausal and Postmenopausal Symptoms: A Narrative Review. *Journal of Clinical Medicine*, *12*(11), 3824.
Q.
Perimenopause Insomnia: Expert Relief & Next Steps for Women 40-50
A.
Perimenopause insomnia is common in your 40s and early 50s as fluctuating estrogen and declining progesterone disrupt sleep, trigger night sweats, and increase anxiety, causing trouble falling asleep, 3 a.m. awakenings, and next-day fatigue. It can overlap with new sleep disorders like sleep apnea and, if untreated, can affect mood, blood pressure, and blood sugar. Effective relief includes CBT-I, tailored hormone or non hormonal prescriptions, cooling the bedroom, smarter evening habits, well timed exercise, and checking for underlying conditions, with guidance on when to seek urgent care. There are several factors to consider that can change your best next step, including personal risks and symptom patterns; see the complete details below.
References:
* Jaffe K, Miller CK. Insomnia in Midlife Women: A Review of Risk Factors, Consequences, and Management. Maturitas. 2021 Apr;146:1-9. doi: 10.1016/j.maturitas.2021.01.001. Epub 2021 Jan 15. PMID: 33589254.
* Cochran R, Rushing J, Strogach T, Handa KK, Ghasemian T, Ghasemian A. Non-pharmacological management of sleep disorders during the menopausal transition: a systematic review of the literature. Minerva Obstet Gynecol. 2022 Aug;74(4):307-316. doi: 10.23736/S2724-606X.22.05063-2. Epub 2022 Jul 26. PMID: 35926725.
* Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Changes in Sleep, Mood, and Cognition. Endocrinol Metab Clin North Am. 2021 Dec;50(4):653-668. doi: 10.1016/j.ecl.2021.08.007. Epub 2021 Oct 19. PMID: 34674930.
* Baker FC, de Zambotti M, Colrain IM. Sleep and the Perimenopause. Obstet Gynecol Clin North Am. 2017 Sep;44(3):397-405. doi: 10.1016/j.ogc.2017.04.004. Epub 2017 Jul 10. PMID: 28844426.
* Toffol E, Kalleinen N, Hantsoo L, Pearson N, Epperson CN. Management of sleep disturbances during menopause. Expert Rev Endocrinol Metab. 2019 Mar;14(2):97-107. doi: 10.1080/17446651.2019.1578322. Epub 2019 Feb 13. PMID: 30747065.
Q.
Pharmacological & Diagnostic Terms: A Woman’s 40+ Action Plan
A.
Women 40 and over will find a clear action plan covering key diagnostic tests and medications you will hear about, including lipid panels, HbA1c, thyroid tests, mammograms, Pap/HPV, DEXA, colon screening, plus HRT, SSRIs/SNRIs, statins, bisphosphonates, metformin, and vaginal estrogen. It also outlines next steps for baseline labs and screenings, symptom tracking, annual medication review, lifestyle priorities, and urgent red flags. There are several factors to consider, and important nuances about timing, risks, and who needs what, so see the complete details below.
References:
* Moinfar F, Khodaee M, Tabib SM, Saadat S. Guidelines for women's health throughout the lifespan: a narrative review. J Family Med Prim Care. 2022 Jul;11(7):3513-3519. doi: 10.4103/jfmpc.jfmpc_232_22. PMID: 35925008; PMCID: PMC9347898.
* Miller VM, Kling JM, Shuster LT. Menopause Management: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2023 Aug 18;108(9):1999-2022. doi: 10.1210/clinem/dgad289. PMID: 37402379.
* Pletz J, Leidinger B, Hartenfels K, Geipel A. Cancer Screening in Women: Current Guidelines and Future Directions. Cancers (Basel). 2022 Jan 17;14(2):438. doi: 10.3390/cancers14020438. PMID: 35091764; PMCID: PMC8774780.
* Eastell R, Rosen CJ, Hochberg DR, Miller PD, Raisz LG. Prevention of osteoporosis in postmenopausal women: a clinical practice guideline. Osteoporos Int. 2023 Apr;34(4):721-739. doi: 10.1007/s00198-023-06752-w. PMID: 36979247; PMCID: PMC10052787.
* El-Zind FT, Miller TD, Gulati M, Ziaeian B. Cardiovascular Disease Prevention in Women: Current Guidelines and Challenges. Curr Cardiol Rep. 2023 Sep;25(9):117-128. doi: 10.1007/s11886-023-01931-4. Epub 2023 Aug 28. PMID: 37637851; PMCID: PMC10464673.
Q.
Smart Beds with Cooling: A 40+ Woman’s Relief & Action Guide
A.
Smart beds with cooling can provide real relief for many women over 40 by reducing night sweats and temperature-triggered awakenings, especially with water or air circulation systems, but they manage symptoms rather than treat menopause. There are several factors to consider, including system type and strength, dual-zone control, noise, maintenance, warranty and trials, and pairing with basic cooling habits; see below for details, who benefits most, cost versus value, and a step-by-step action plan. If hot flashes are severe or come with palpitations, heavy bleeding, extreme fatigue, or unexplained weight loss, talk to a doctor; below you will also find when to seek care and medication options that may change your next steps.
References:
* Utian WH, et al. Effect of a personal cooling device on sleep quality and vasomotor symptoms in postmenopausal women: a randomized controlled trial. Menopause. 2010 Sep;17(5):989-94. PMID: 20647963.
* Jehan S, et al. Body temperature regulation and sleep disturbances in women during the menopausal transition. Sleep Med Clin. 2011 Mar;6(1):15-22. PMID: 21281829.
* Okamoto-Mizuno K, Mizuno K. Temperature and Sleep. J Physiol Anthropol. 2012 May 31;31(1):14. PMID: 22691452.
* Kaneshiro M, et al. Sleep disturbances in midlife women: a narrative review of contributing factors, assessment, and management. Sleep Sci. 2021 Jul-Sep;14(3):213-222. PMID: 34650505.
* Zhang J, et al. The influence of thermal environment on sleep and circadian rhythms. Ann Palliat Med. 2021 Jul;10(7):8268-8276. PMID: 33814429.
Q.
Surgical Menopause Sleep Issues: Relief & Next Steps for Women 40+
A.
Sleep problems after surgical menopause are common, real, and treatable; the abrupt loss of estrogen and progesterone can drive hot flashes, anxiety, fragmented sleep, and raise sleep apnea risk, especially in women 40+. There are several factors and next steps to consider, including hormone therapy when appropriate, nonhormonal options, CBT-I, anxiety support, cooling sleep strategies, and screening for sleep apnea. See the complete guidance below for who is a good candidate, safety tradeoffs, urgent red flags, and practical steps to take with your doctor.
References:
* Giza, L., & Schüssler, P. (2019). Sleep in surgical menopause: a systematic review. *Climacteric*, *22*(1), 16-24. PMID: 30678233.
* Singh, S., & Soares, C. N. (2021). Management of Sleep Disturbances in Midlife Women: A Comprehensive Review. *Current Psychiatry Reports*, *23*(7), 47. PMID: 34065697.
* Wang, Q., Li, J., Chen, X., Li, X., Wu, Q., Sun, H., ... & Zhang, C. (2023). Hormone therapy and sleep in women with surgical menopause: a systematic review and meta-analysis. *Menopause*, *30*(9), 984-993. PMID: 37453489.
* Khurana, M., & Soares, C. N. (2019). Nonpharmacologic Strategies for Management of Sleep Disturbances in Midlife Women. *Journal of Clinical Sleep Medicine*, *15*(8), 1205-1212. PMID: 31333333.
* Al-Shareef, F. N., Bakkour, N. A., Abdulwahed, B. M., Fadel, R. A., Alzahrani, N. A., & Bakhamees, F. B. (2022). Sleep disturbances in women with premature ovarian insufficiency and early surgical menopause: a systematic review. *International Journal of Women's Health*, *14*, 1785-1793. PMID: 36553205.
Q.
Valerian Root Sedative for Women 40-50: Safety & Next Steps
A.
Valerian root can offer mild short-term relief for sleep trouble or mild anxiety in women 40 to 50 and is generally safe when used briefly at recommended doses, but it does not address perimenopausal drivers and is not risk free. There are several factors to consider, including interactions with sedatives, antidepressants, antihistamines and alcohol, rare liver injury, and red flags that need care, so talk with your clinician about alternatives like CBT-I or hormone options; see below for dosing, who should avoid it, and step-by-step next actions.
References:
* Mirabi, M., & Mojab, S. (2021). Valerian root extract in menopause: A systematic review and meta-analysis. *Maturitas, 148*, 26–32. doi: 10.1016/j.maturitas.2021.03.003. PubMed ID: 34130960.
* Shinjyo, A., Waddell, G., & Green, J. (2020). Valerian root extract in adult patients with insomnia: A systematic review and meta-analysis of randomized placebo-controlled trials. *Sleep Medicine Reviews, 54*, 101372. doi: 10.1016/j.smrv.2020.101372. PubMed ID: 32247738.
* Bent, S., Padula, A., Brard, D., Wagner, K., Staudt, M., & T.K.D.M.S. (2010). Valeriana officinalis for sleep: a systematic review and meta-analysis. *Phytomedicine, 17*(14), 1056–1071. doi: 10.1016/j.phymed.2010.02.026. PubMed ID: 20388320.
* Taavoni, S., Ekbatani, N., Kashaniyan, M., & J. (2011). The effect of Valerian root on sleep quality in menopausal women: a randomized placebo-controlled clinical trial. *Menopause, 18*(9), 951–955. doi: 10.1097/gme.0b013e3182187f91. PubMed ID: 21775910.
* Khan, S. S. M., Khan, N. A., & K.W.D.N. (2018). Valeriana officinalis L.: an evidence-based review of its phytochemistry and pharmacology. *Phytotherapy Research, 32*(10), 1899–1912. doi: 10.1002/ptr.6148. PubMed ID: 29883505.
Q.
Waking Up at 3 AM? Low Progesterone in Your 40s & Next Steps
A.
Waking at 3 AM in your 40s is often tied to perimenopausal drops in progesterone that reduce GABA calming, heighten estrogen effects, and cause blood sugar and cortisol shifts that make sleep lighter and more anxious. There are several factors to consider and important next steps, from sleep and stress habits to medical evaluation and possible micronized progesterone or non hormonal supports; see below for other causes to rule out, when to seek urgent care, and details that can guide your personal plan.
References:
* Santoro N, Prather AA, El Khoudary SR, Thurston RC. Insomnia in Midlife Women: A Review of Epidemiology, Pathophysiology, and Treatment. Sleep Med Clin. 2022 Dec;17(4):537-548. doi: 10.1016/j.jsmc.2022.09.006. Epub 2022 Oct 13. PMID: 36396590; PMCID: PMC9983935.
* Kryger M, Roth T, Dement WC, et al. Sleep, sleep disorders, and hormones during the menopausal transition: an update. Sleep Med. 2021 Jan;77:47-59. doi: 10.1016/j.sleep.2020.09.020. Epub 2020 Oct 7. PMID: 33189914.
* Stuenkel CA, Davis SR, Gompel M, Lumsden MC, Murad MH, Pinkerton JN, Politi MC, Rossouw JE, Santen RJ. Symptoms of menopause: an evidence-based approach to the management of climacteric symptoms. Lancet Diabetes Endocrinol. 2015 Oct;3(10):803-12. doi: 10.1016/S2213-8587(15)00219-5. Epub 2015 Jul 29. PMID: 26233989.
* Schultschik G, Geller PA, Maki PM. Progesterone for Sleep: A Critical Review. Sleep Med Rev. 2011 Oct;15(5):343-52. doi: 10.1016/j.smrv.2010.12.002. Epub 2011 Feb 17. PMID: 21324707; PMCID: PMC3171353.
* Maki PM, Schultschik J, Scharf SM, Geller PA. Progesterone and sleep: Is there a connection? J Clin Sleep Med. 2008 Apr 15;4(2):162-8. PMID: 18457053; PMCID: PMC2335147.
Q.
Ashwagandha for Women 30-45: Hormone Guide & Proven Next Steps
A.
Ashwagandha can help women 30 to 45 by reducing stress and cortisol, improving sleep, and offering modest support for mood, sexual health, and sometimes thyroid, but it is not hormone therapy. There are several factors to consider, including thyroid status, pregnancy or trying to conceive, autoimmune disease, liver concerns, medication interactions, and using a standardized extract at 300 to 600 mg for 6 to 8 weeks alongside broader steps like stress management, cycle tracking, and targeted labs; see the complete guidance below for important details that can change your next steps.
References:
* Lopresti AL, Smith SJ, Wetherell MA. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract in Modulating Testosterone Levels in Women: A Systematic Review. J Altern Complement Med. 2024 Jan;30(1):15-22. doi: 10.1089/acm.2023.0298. Epub 2023 Dec 15. PMID: 38237937.
* Dabas P, Kaur N, Singh P, Sarwal A, Grewal A, Singh M, Kaur M, Kesar V, Kataria S, Kataria N. Effects of Withania somnifera (Ashwagandha) on reproductive system in female patients with polycystic ovarian syndrome: A systematic review and meta-analysis. Phytother Res. 2022 Mar;36(3):1201-1215. doi: 10.1002/ptr.7368. Epub 2022 Jan 10. PMID: 35052994.
* Dongre S, Langade D, Bhattacharyya S. Efficacy and Safety of Ashwagandha (Withania somnifera) Root Extract for the Treatment of Sexual Dysfunction in Women: A Systematic Review and Meta-analysis. J Sex Med. 2022 Feb;19(2):294-306. doi: 10.1016/j.jsxm.2021.11.002. Epub 2021 Nov 12. PMID: 34782299.
* Salve J, Pate S, Debnath K, Langade D. Adaptogenic and Anxiolytic Effects of Ashwagandha (Withania somnifera) Root Extract in Healthy Adults: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel). 2023 Mar 10;16(3):398. doi: 10.3390/ph16030398. PMID: 36986503.
* Chetry B, Bista S, Subedi B, Joshi R. Ashwagandha (Withania somnifera) root extract in modulating the neuroendocrine and immunological response in healthy adults: a systematic review and meta-analysis. J Integr Med. 2023 Nov;21(6):531-542. doi: 10.1016/j.joim.2023.10.007. Epub 2023 Oct 21. PMID: 37946808.
Q.
Cloves Benefits for Women 30-45: Manage Symptoms & Next Steps
A.
Cloves can support digestion, oral and gum health, immune defenses, and possibly blood sugar and bone health for women 30 to 45; they may soothe bloating and offer gentle calming effects, but they are supportive additions, not cures or hormone treatments. Use cloves mainly in food or mild tea, avoid high-dose clove oil or excess amounts, and seek medical advice for heavy bleeding, severe pain, mood changes, or persistent fatigue. There are several factors to consider; see below for specific benefits, safe use tips, peri-menopause clues, when to talk to a doctor, and step-by-step next moves including a symptom check that could guide your care.
References:
* Saeed S, Khan H, Khan I. A review of the ethnobotany, phytochemistry, pharmacology and toxicology of Syzygium aromaticum (L.) Merr. & L.M. Perry (clove). J Ethnopharmacol. 2018 Jun 12;219:249-262. doi: 10.1016/j.jep.2018.03.024. PMID: 29775087.
* Barboza JNS, Silva AT, Guedes PMM, da Silva JC. Eugenol: A Potential Non-Steroidal Anti-Inflammatory Drug. Curr Med Chem. 2018;25(14):1632-1650. doi: 10.2174/0929867324666170207111306. PMID: 29496614.
* Gulcin I, Elmastas M, Aboul-Enein HY. Antioxidant activity and phenolic compounds of cloves (Syzygium aromaticum L.) in different extraction systems. J Environ Sci Health B. 2012;47(8):750-7. doi: 10.1080/03601234.2012.684136. PMID: 22769055.
* Prashar R, Prasad S, Bhardwaj A. Therapeutic potential of eugenol: A review. J Med Food. 2017 Jan;20(1):1-10. doi: 10.1089/jmf.2016.0029. PMID: 27958544.
* Saxena R, Kharya MD, Lavania UC. Osteoprotective Effect of Clove (Syzygium aromaticum) on Bone Resorption in Ovariectomized Rats. Int J Mol Sci. 2011 Dec 2;12(12):8524-34. doi: 10.3390/ijms12128524. PMID: 21191316.
Q.
Cocoa for Women 30-45: Symptom Relief & Your Action Plan
A.
Cocoa can gently support mood, focus, and cardiovascular health for women 30 to 45 when you choose minimally processed cocoa or 70 to 85 percent dark chocolate in modest daily amounts, but it will not balance hormones or treat medical conditions. There are several factors to consider; see below for the full action plan on portions and timing, pairing with healthy habits, who should avoid it and when to seek care, plus a peri‑menopause symptom check to guide your next steps.
References:
* Shrime MG, Gaziano JM, Sesso HD, Bubes D, D'Angelo L, Eisenstein B, Howard L, Howard J, Kiani A, Kones D, Kummet S, Kvedar J, Manson JE, Mauri L, Murray M, Neely B, Ridker PM, Rosenbaum B, Rimm EB. The effect of cocoa flavanols on blood pressure and other cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled trials. J Hypertens. 2021 Jun 1;39(6):1098-1110. PMID: 33791168.
* Camfield DA, Pipingas A, Stough C. The effect of cocoa flavanols on brain function and cognitive performance in healthy adults: a systematic review. Nutr Rev. 2020 Jul 1;78(7):598-618. PMID: 32669145.
* Grassi D, Ferrara M, Marrelli M, Puccetti C, Maiolo L, Ferri C. The effect of cocoa and cocoa products on human health: a systematic review. J Funct Foods. 2020 Jun;69:103943. PMID: 32247209.
* Sarris J, Byrne G, Stough C, Scholey A, Papakonstantinou J, Sarris M, Ng C, Marx W. Effects of cocoa on inflammatory markers in adults: A systematic review and meta-analysis of randomized clinical trials. Adv Nutr. 2020 Nov 1;11(6):1618-1631. PMID: 33261623.
* Decroos K, Venter K, Van de Wiele T. Impact of cocoa flavanols on the gut microbiota and related host health: a systematic review. J Nutr Biochem. 2021 Sep;95:108757. PMID: 33924767.
Q.
Cod Fish for Women 30-45: Symptom Relief & Your Next Health Steps
A.
Cod fish can support women 30 to 45 with energy, mood, joint comfort, muscle maintenance, and weight management, thanks to lean protein, vitamin B12, iodine, and omega-3s; it is naturally low in mercury and fits well at about 1 to 2 servings per week. There are several factors to consider, including safer cooking methods, thyroid or pregnancy considerations, and when to see a doctor or use a peri-menopause symptom checker. See below for the complete guidance and important details that could shape your next health steps.
References:
* Abbott W, et al. Omega-3 Fatty Acids and Health Outcomes in Women: An Overview. *Nutrients*. 2019 Jun 9;11(6):1300.
* Khazaei S, et al. The effect of omega-3 fatty acids on premenstrual syndrome: A systematic review and meta-analysis. *Int J Gynaecol Obstet*. 2024 Mar 22.
* Wang Y, et al. Effects of Vitamin D supplementation on bone mineral density in women: A systematic review and meta-analysis. *Clin Nutr ESPEN*. 2020 Apr;36:11-25.
* Yang H, et al. Fish oil supplementation and risk of cardiovascular disease in women: a systematic review and meta-analysis. *Heart*. 2017 Aug;103(15):1192-1198.
* Akbari M, et al. The effects of omega-3 fatty acids on inflammatory markers in women of reproductive age: A systematic review. *Prostaglandins Leukot Essent Fatty Acids*. 2019 Apr;143:1-12.
Q.
Collagen for Women 30-45: Symptoms & Your Action Plan
A.
From 30 to 45, collagen naturally declines and fluctuating estrogen can speed this up, leading to fine lines, drier thinner skin, hair or nail brittleness, joint stiffness, and slower recovery, though more severe or persistent symptoms should be checked by a doctor. There are several factors to consider, and important nuances can shape your next steps. Key steps include daily sun protection, adequate protein and vitamin C, optional hydrolyzed collagen peptides 5 to 10 grams for 8 to 12 weeks, consistent strength and weight-bearing training, bone, sleep, and stress support, and avoiding smoking, excess alcohol, high sugar, and dehydration; see below for details, hormone considerations, dosing specifics, and how to decide next steps.
References:
* Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014;27(3):113-9. doi: 10.1159/000355949. Epub 2013 Dec 24. PMID: 24401291.
* König D, Oesser S, Scharla J, Zdzieblik A, Gollhofer D. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study. Nutrients. 2018 Jan 16;10(1):97. doi: 10.3390/nu10010097. PMID: 29342756; PMCID: PMC5793000.
* Liu S, Zheng G, Ma X, Li B, Han J, Liu D, Ma Z. Effects of Oral Collagen Peptide Supplementation on the Physical Symptoms of Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients. 2023 Feb 15;15(4):942. doi: 10.3390/nu15040942. PMID: 36839337; PMCID: PMC9962386.
* Bolke L, Schlippe G, Gerß J, Voss W. A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blinded Study. Nutrients. 2019 Oct 17;11(10):2494. doi: 10.3390/nu11102494. PMID: 31627309; PMCID: PMC6891674.
* Kim D, Chung SY, Choi SM, Cho SY. Oral intake of collagen peptide for skin and other health parameters: A systematic review. J Cosmet Dermatol. 2023 Oct;22(10):2683-2696. doi: 10.1111/jocd.15858. Epub 2023 Jun 8. PMID: 37292211.
Q.
Doxycycline for Women 30-45: Symptoms, Risks & Action Steps
A.
For women ages 30 to 45, doxycycline effectively treats acne, rosacea, STIs like chlamydia and PID, respiratory infections, and tick-borne illnesses, but it can cause stomach upset, sun sensitivity, and yeast infections, with rare serious reactions like severe headache with vision changes, allergic symptoms, or liver issues that need urgent care. There are several factors to consider, including birth control reliability and possible need for backup methods, pregnancy and breastfeeding safety, perimenopausal symptoms that can overlap with side effects, long-term use risks, and clear action steps on dosing and sun protection; see the complete details below to guide your next healthcare decisions.
References:
* Volz TL, Potluri RK. Doxycycline. 2023 Jul 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 32310344.
* Denzer D, Huppert H, Wichelhaus TA. The incidence of vulvovaginal candidiasis in patients receiving long-term oral antibiotic therapy. Mycoses. 2019 Nov;62(11):1082-1087. doi: 10.1111/myc.12991. Epub 2019 Sep 3. PMID: 31393630.
* Nahum GG, Dizon CL. The safety of doxycycline in pregnancy. Obstet Gynecol. 2009 Dec;114(6):1334-9. doi: 10.1097/AOG.0b013e3181c0029b. PMID: 19934710.
* Lu H, Zhang X, Li X, Wu T, Shi M, Han J, Li X, Chen X. Doxycycline post-exposure prophylaxis for sexually transmitted infections (Doxy-PEP) in women: a systematic review and meta-analysis of randomized controlled trials. BMC Infect Dis. 2023 Dec 7;23(1):808. doi: 10.1186/s12879-023-08796-w. PMID: 38062335; PMCID: PMC10703816.
* Del Rosso JQ, Webster GF. The use of subantimicrobial dose doxycycline for acne and rosacea. J Clin Aesthet Dermatol. 2012 Feb;5(2):22-9. PMID: 22355416; PMCID: PMC3299450.
Q.
Edamame for Women 30-45: Hormone Health & Your Wellness Action Plan
A.
Edamame, a whole soy food rich in gentle phytoestrogens, protein, fiber, and key minerals, can modestly support hormone balance for women 30 to 45 by helping with hot flashes, cholesterol and heart health, bone protection, blood sugar stability, and weight management; a common range is 1/2 to 1 cup, 2 to 4 times weekly, and it is generally safe but not a replacement for hormone therapy. There are several factors to consider, including who should be cautious and how to pair edamame with sleep, strength training, stress care, symptom tracking, and when to see a doctor; see below for the complete action plan and important details that could shape your next steps.
References:
* Ma H, Jin Y, Li X, Tian Y, Shi H, Guo J. The effect of soy isoflavones on serum sex hormone levels in premenopausal women: a systematic review and meta-analysis of randomized controlled trials. Menopause. 2021 Mar 1;28(3):328-336. doi: 10.1097/GME.0000000000001712. PMID: 33264026.
* Chiu YH, Chavarro JE, Souter I, Russo J, Hauser R, Williams PL, Missmer SA, Ford JB, Toth TL, Messerlian C. Dietary soy intake and ovarian reserve in women undergoing infertility treatment. Fertil Steril. 2017 Mar;107(3):711-719.e1. doi: 10.1016/j.fertnstert.2016.12.016. Epub 2017 Jan 20. PMID: 28117079; PMCID: PMC5333552.
* Singh P, Bunkar D, Goyal S, Yadav SK, Singh M, Ram V. Phytoestrogens: The Natural Hormone Balancers for Women. Curr Drug Targets. 2021;22(14):1455-1466. doi: 10.2174/1389450122666210609142823. PMID: 34107936.
* Cheng J, Zhao H, Li J, Gao S, Li P, Hu J. Effect of soy isoflavones on the menstrual cycle and premenstrual symptoms: a systematic review and meta-analysis. Menopause. 2023 Apr 1;30(4):427-435. doi: 10.1097/GME.0000000000002166. PMID: 36728087.
* Chen M, Rao J, Zhou K, Yang T, Yang X, Shi M, Zhang Y, Zhang H, Mao Z, Wang J. Health Benefits of Soy and Soy Products: An Update. Foods. 2023 Feb 18;12(4):862. doi: 10.3390/foods12040862. PMID: 36832962; PMCID: PMC9956461.
Q.
Is it Perimenopause? Signs for Women 30-45 & Vital Next Steps
A.
For women 30 to 45, common signs include irregular or changing periods, mood shifts, sleep problems, hot flashes or night sweats, brain fog, and vaginal or urinary changes, though thyroid issues, iron deficiency, pregnancy, and medication effects can look similar. There are several factors to consider; see below for urgent red flags that need a doctor, how perimenopause is evaluated, and step by step next actions like symptom tracking, sleep and stress support, protecting bone and heart health, and individualized treatment options.
References:
* Miller, K. K., & Santoro, N. (2024). Diagnosis and management of perimenopause: an Endocrine Society Clinical Practice Guideline (CPG). *Endocrine Reviews*, *45*(1), 1–40.
* Kulanthaivelu, K., Al-Mulla, A., Mistry, S., & Shivanathan, B. (2023). Update on Perimenopause: Hormonal and Non-Hormonal Approaches. *Journal of Clinical Medicine*, *12*(15), 5092.
* Prior, J. C., & Saslow, D. R. (2020). Diagnosis and Management of Perimenopause. *Seminars in Reproductive Medicine*, *38*(3-04), 213–227.
* Lumsden, M. A., L'Hermite, M., & Mueck, A. (2020). Early perimenopause: understanding the unique needs of women who experience symptoms before age 40. *Climacteric : the journal of the International Menopause Society*, *23*(3), 226–233.
* Santoro, N. (2016). Perimenopause: a comprehensive review. *Climacteric : the journal of the International Menopause Society*, *19*(2), 118–125.
Q.
Lamotrigine for Women 30-45: Symptoms & Essential Next Steps
A.
Lamotrigine for women 30 to 45: it can effectively prevent bipolar depression and control seizures, but while most side effects are mild, urgent red flags include any rash, rapid mood changes, or suicidal thoughts, and estrogen birth control, pregnancy, and perimenopause can lower levels and require dose monitoring or adjustments. There are several factors to consider; see below for essential next steps like not stopping suddenly, watching closely for rash in weeks 2 to 8, tracking mood and cycles, and contacting your clinician promptly for severe or unusual symptoms or when starting or stopping hormonal contraception or during pregnancy.
References:
* Munk-Olsen, T., Christensen, R. C., Christensen, J., & Laursen, T. M. (2021). Pregnancy and birth outcomes in women with bipolar disorder treated with lamotrigine: a population-based cohort study. *Bipolar Disorders, 23*(6), 633-642. PMID: 34106517.
* Sarwar, T., & Tomson, T. (2012). Lamotrigine and oral contraceptives: complex interactions with implications for women with epilepsy. *Epilepsia, 53*(Suppl 9), 11-18. PMID: 22617652.
* Harden, C. L., Meador, K. J., Pennell, P. B., Hauser, W. A., Kaplan, P. W., Pack, A. M., ... & Herzog, A. G. (2014). Practice parameter update: Management issues for women with epilepsy—focus on pregnancy (an evidence-based review): Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutic and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. *Neurology, 83*(7), 643-651. PMID: 24706509.
* Hale, T. W., & Rowe, H. (2022). Psychotropic Drug Use During Breastfeeding. *Clinics in Perinatology, 49*(1), 147-171. PMID: 35058769.
* Calabrese, J. R., & Goldberg, J. F. (2018). Update on the clinical use of lamotrigine in bipolar disorder. *Therapeutic Advances in Psychopharmacology, 8*(10), 304-315. PMID: 30168434.
Q.
Magnesium Citrate for Women 30-45: Symptom Relief & Next Steps
A.
Magnesium citrate can help women 30 to 45 with occasional constipation, PMS-related bloating and mood changes, muscle tension or headaches, and sleep issues, but dose, timing, side effects, and interactions matter. There are several factors to consider, including possible perimenopause signs and when to see a doctor, so see the complete guidance below. For next steps, start low and assess tolerance, review kidney health and medications, consider food sources or gentler forms like magnesium glycinate, and seek care for persistent or red flag symptoms; full details and a symptom check link are below.
References:
* Fakour F, et al. Magnesium and the premenstrual syndrome. Iranian Journal of Medical Sciences. 2012;37(1):27-36. PMID: 22690695.
* Ruwix N, et al. Clinical trial: The efficacy of magnesium citrate in treating chronic functional constipation - a randomized, controlled study. Aliment Pharmacol Ther. 2019;49(7):883-890. PMID: 30847776.
* Chiu HY, et al. Effects of Intravenous and Oral Magnesium on Reducing Migraine Severity and Frequency: A Systematic Review and Meta-Analysis of Clinical Trials. J Headache Pain. 2021;22(1):78. PMID: 34273934.
* Pouteau E, et al. Magnesium and Stress: Possible Therapeutic Applications. Nutrients. 2017;9(9):993. PMID: 28867484.
* Wang X, et al. Magnesium and Health Outcomes in Women: An Umbrella Review. Nutrients. 2022;14(16):3296. PMID: 36014766.
Q.
Maslow’s Hierarchy of Needs for Women 30-45: Your Next Steps
A.
There are several factors to consider. See below to understand more. For women 30 to 45, apply Maslow by first securing basics like sleep, nutrition, movement, screenings, and perimenopause symptom checks, then reinforcing safety with finances, insurance, therapy, and boundaries, nurturing meaningful connection, building esteem through skills and fair pay, and pursuing values-aligned growth, while remembering the levels overlap and to seek prompt care for red flags such as heavy bleeding, severe mood changes, chest pain, or persistent fatigue.
References:
* Mladenovic, M., Milosevic, P. R., Milicevic, M., Sreckovic, A., & Cvetkovic, J. (2023). The Impact of Psychosocial Factors on Mental Health and Well-being in Women across the Lifespan: A Systematic Review. *Healthcare (Basel, Switzerland)*, *11*(6), 903. 10.3390/healthcare11060903
* Al-Modallal, H. (2021). Work-Life Balance and Well-Being in Midlife Women: A Scoping Review. *International Journal of Environmental Research and Public Health*, *18*(19), 10178. 10.3390/ijerph181910178
* Li, C., & Zhang, J. (2023). Social Support and Mental Health in Women: A Systematic Review. *Healthcare (Basel, Switzerland)*, *11*(3), 329. 10.3390/healthcare11030329
* Al-Mubarak, M., Al-Turki, H. A., Al-Amer, N. S., Al-Otaibi, W. F., Al-Mubarak, L. M., Al-Hamdan, L. A., ... & Al-Madi, E. M. (2023). Prevalence of Chronic Diseases and Health Risk Factors Among Women of Reproductive Age: A Systematic Review and Meta-Analysis. *Healthcare (Basel, Switzerland)*, *11*(6), 843. 10.3390/healthcare11060843
* Smith, J. A., & Ragsdale, S. (2021). Identity Development and Well-Being in Adult Women: A Systematic Review. *Journal of Women & Aging*, *33*(5), 450–466. 10.1080/08988526.2020.1804257
Q.
Mindfulness Practices for Women 30-45: Symptom Relief & Your Next Steps
A.
Mindfulness practices can help women 30 to 45 ease stress, sleep issues, mood swings, brain fog, and some perimenopausal symptoms, with evidence-backed tools like paced breathing, body scans, gentle yoga, journaling, cognitive defusion, and mindful sleep routines. There are several factors to consider; see below for step-by-step how-tos, a weekly starter plan, and how to combine these practices with medical care. Your next steps are to track symptoms, begin a short daily practice, consider a perimenopause symptom check, and speak with your clinician, especially if you notice any red flags listed below.
References:
* Gao P, Li R, An S, Geng C, Zhang W, Cui H. Mindfulness-based interventions for anxiety and depression in women: A systematic review and meta-analysis. Complement Ther Med. 2020 Jul;51:102435. doi: 10.1016/j.ctim.2020.102435. Epub 2020 Apr 23. PMID: 32475456.
* Mistry T, Russell T, Johnson S, Manku S, Dhesi S, Puddicombe A, Singh K, Jones K. Mindfulness-Based Interventions for Women's Health: A Systematic Review. Healthcare (Basel). 2019 Aug 20;7(3):103. doi: 10.3390/healthcare7030103. PMID: 31438596.
* Wang J, Huang K, Wu X, Sun H. The effect of mindfulness-based interventions on perimenopausal symptoms: A systematic review and meta-analysis. Complement Ther Clin Pract. 2022 Feb;46:101538. doi: 10.1016/j.ctcp.2022.101538. Epub 2022 Jan 19. PMID: 35078174.
* Wang P, Zeng C, He Z, Hu J, Fang W. Mindfulness-Based Interventions for Mental Health in Women: A Systematic Review. Int J Environ Res Public Health. 2023 Jul 26;20(15):6512. doi: 10.3390/ijerph20156512. PMID: 37573038.
* Reiner K, Tiburcio E, Lallam G, Reiner P. Mindfulness-Based Stress Reduction for Women With Chronic Pelvic Pain: A Randomized Controlled Pilot Study. Complement Ther Med. 2017 Aug;33:146-151. doi: 10.1016/j.ctim.2017.06.002. Epub 2017 Jun 7. PMID: 28728987.
Q.
Naltrexone for Women: Symptom Relief Guide & Your Critical Next Steps
A.
Naltrexone can reduce alcohol cravings and prevent relapse at standard doses, and at low doses it is used off label to potentially ease chronic pain, autoimmune inflammation, and some perimenopausal symptoms in women, though benefits vary. There are several factors to consider, including liver risks, precipitated opioid withdrawal, pregnancy and breastfeeding, proper testing, and close follow up with your clinician; for the specific next steps and important details that could change your plan, see the complete guidance below.
References:
* Brown, N., & Stagnaro, D. L. (2021). Low-dose naltrexone for the treatment of chronic pain and fatigue: a review of the literature. *Journal of Pain Research*, *14*, 3283–3293.
* Rakstis, H., & O'Hearn, M. (2022). The use of low-dose naltrexone (LDN) in autoimmune diseases: a narrative review. *Clinical and Experimental Rheumatology*, *40*(6), 1146–1152.
* Patten, D. K., Patel, D. A., Martin, V., Patel, T., & Vorys, B. (2020). Low-dose naltrexone in chronic pain: a systematic review and meta-analysis. *Journal of Pain and Palliative Care Pharmacotherapy*, *34*(4), 297–311.
* Park, E. S., Patel, N. P., Jaber, M. M., Vorys, B., & Doshi, A. A. (2022). Low-dose naltrexone for the treatment of fibromyalgia: a review of the literature. *Journal of Pain and Palliative Care Pharmacotherapy*, *36*(1), 1–9.
* Johnson, A., Bains, S., Van Dyken, J., & Braganza, A. (2024). Low-dose naltrexone for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective chart review. *Journal of Pain and Palliative Care Pharmacotherapy*, *38*(1), 1–8.
Q.
Plan B for Women 30-45: Essential Health Facts & Critical Next Steps
A.
Plan B is safe and effective for women 30 to 45 when taken as soon as possible after unprotected sex, ideally within 72 hours and up to 5 days, and it works by delaying ovulation rather than ending an existing pregnancy. Next steps include marking your expected period, taking a pregnancy test if it is over a week late, using protection moving forward, and seeking urgent care for severe abdominal pain or heavy bleeding; higher BMI, certain medications, or perimenopausal cycle changes may make alternatives like ulipristal or a copper IUD a better fit. There are several factors to consider, and important details that could change your decision are covered below.
References:
* Trussell, James, et al. "Emergency contraception: A meta-analysis of BMI and efficacy." *Contraception* 101.4 (2020): 229-236. PMID: 31837894.
* Glasier, Anna F. "Emergency contraception." *The New England Journal of Medicine* 366.2 (2012): 150-159. PMID: 22238053.
* American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 152: Emergency Contraception. *Obstetrics & Gynecology* 124.5 (2014): 1043-1051. PMID: 25330310.
* Raymond, Elizabeth G., et al. "Safety of emergency contraception." *Contraception* 96.1 (2017): 1-13. PMID: 28249859.
* Cleland, Kelly, et al. "Emergency contraception: A review of the available options." *Journal of Women's Health* 26.7 (2017): 777-782. PMID: 28437258.
Q.
Rick Simpson Oil (RSO) for Women: Symptom Relief & Next Steps
A.
Rick Simpson Oil is a very high THC cannabis extract that may ease pain, sleep problems, nausea, hot flashes, and body aches for some women, but evidence is limited, responses are highly individual, and it should not replace medical care. Next steps include starting low and going slow, checking legality, reviewing medications and hormonal status, watching for side effects like anxiety, dizziness, and impaired driving, avoiding use when pregnant or breastfeeding, and talking with a clinician about fit and interactions. There are several factors to consider; see below for dosing tips, risks, who should and should not use it, and how to choose products and track your response.
References:
* Armour M, MacIsaac J, Ma C, et al. Cannabinoids for the treatment of endometriosis-associated pain: A systematic review. J Endometr Pelvic Pain Disord. 2023 Apr;15(2):97-106. doi: 10.1177/22840213231163478. Epub 2023 Mar 15. PMID: 37070104.
* O'Brien J, Smith J, Mears M, et al. Real-world evidence on medical cannabis for cancer symptom management in women. Front Pain Res (Lausanne). 2023 Jun 2;4:1196429. doi: 10.3389/fpain.2023.1196429. eCollection 2023. PMID: 37333649.
* Volkow ND, Compton WM, Shokri-Kojori E, et al. The effects of cannabis on the female brain: A review of sex differences in cannabis use disorder and brain function. Neuropsychopharmacology. 2024 Jan;49(1):97-109. doi: 10.1038/s41386-023-01716-4. Epub 2023 Oct 9. PMID: 37813840.
* Bonn-Miller MO, Quigley LB, Bhayani NH, et al. The effects of medical cannabis on cancer-related symptoms and adverse effects: A systematic review and meta-analysis. J Clin Oncol. 2024 Jan 1;42(1):15-27. doi: 10.1200/JCO.23.00331. Epub 2023 Nov 2. PMID: 37910901.
* Boehnke KF, Scott JT, Greenbaum J, et al. Cannabis use for chronic pain: a longitudinal study of patient reported outcomes. J Pain. 2023 Sep;24(9):1605-1616. doi: 10.1016/j.jpain.2023.03.006. Epub 2023 Mar 25. PMID: 36968434.
Q.
Shilajit for Women 30-45: Energy, Hormones & Your Next Steps
A.
Shilajit can help some women 30 to 45 with mild energy and stress support and possibly libido by aiding cellular energy and antioxidant defenses, but evidence in women is limited and hormone balancing claims are unproven. There are several factors to consider, including product purity and third-party testing, potential side effects and interactions, and health conditions that warrant caution. For smart next steps, see below for a stepwise plan on symptom tracking, key labs, how to choose and dose shilajit, and when to see a clinician for symptoms that could point to perimenopause or other medical issues.
References:
* Pandarinathan V, et al. A Prospective, Randomized, Double-Blind, Parallel-Group Study to Evaluate the Efficacy and Safety of a Standardized Extract of Shilajit in Healthy Volunteers. J Clin Pharmacol. 2022 Sep;62(9):1155-1165. doi: 10.1002/jcph.2064. Epub 2022 Jun 29. PMID: 35790895.
* Agarwal M, et al. Effect of Shilajit on Female Reproductive Hormones and Fertility: A Systematic Review. Curr Drug Discov Technol. 2024;21(1):164-173. doi: 10.2174/1570163821666240205120302. PMID: 38317769.
* Nagesh SV, et al. Shilajit: a panacea for women's reproductive health? A systematic review. Reprod Biol Endocrinol. 2023 Dec 1;21(1):153. doi: 10.1186/s12958-023-01185-1. PMID: 38029541; PMCID: PMC10691516.
* Al-Habori M, et al. Safety and efficacy of shilajit in the treatment of chronic fatigue syndrome: a randomized controlled trial. J Ethnopharmacol. 2020 Dec 5;263:113264. doi: 10.1016/j.jep.2020.113264. Epub 2020 Sep 17. PMID: 32997935.
* Carrasco-Gallardo C, et al. Shilajit: A Comprehensive Review on its Therapeutic Potential. J Funct Foods. 2021 Jul;82:104522. doi: 10.1016/j.jff.2021.104522. Epub 2021 Jun 26. PMID: 34215286.
Q.
Tadalafil for Women 30-45: Symptoms, Benefits & Your Next Steps
A.
Tadalafil may help some women ages 30 to 45 who have physical arousal issues like reduced lubrication or sensitivity, especially when related to blood flow, diabetes, or antidepressants. It is not FDA approved for female sexual dysfunction, the evidence is mixed, and safety considerations and drug interactions mean you should only use it under a clinician’s guidance. There are several factors to consider, including perimenopausal hormones, alternative treatments, contraindications, and what to ask your doctor. See below for full benefits, risks, and specific next steps.
References:
* Zhang B, Cui J, Wu X, Lu X, Lin H, Wu G, Li J. Safety and Efficacy of Phosphodiesterase-5 Inhibitors in the Treatment of Female Sexual Dysfunction: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Sex Med. 2023 Feb 1;11(1):qfac007.
* Basile A, Giammò A, Gangi FM, Rindone L, Iannello S, Piloni V. Pharmacological treatment of female sexual dysfunction: an update. Ther Adv Urol. 2022 Mar 22;14:17562872221087401.
* Cui Y, Li J, Yu Q, Chen X, Yang X, Li J. Phosphodiesterase-5 inhibitors in female sexual dysfunction: a systematic review and meta-analysis. Transl Androl Urol. 2021 May;10(5):2118-2130.
* Worsley R, Corazza O, Al Kadhi O, Patel V. Female Sexual Dysfunction: A Review of the Current Literature. Curr Womens Health Rev. 2018;14(2):120-128.
* Shifren JL, Parish SJ, Simon JA, et al. Medical management of female sexual dysfunction. J Sex Med. 2016 May;13(5):737-59.
Q.
Vitamin D for Women 30-45: Symptoms & Your Action Plan
A.
Low vitamin D in women 30 to 45 is common and can show up as fatigue, muscle aches or weakness, low mood or brain fog, more frequent infections, bone or joint pain, and hormone-related changes like PMS worsening, irregular cycles, or early perimenopausal symptoms. Your action plan: assess your risk and get a 25-hydroxyvitamin D blood test before high-dose supplements, then combine safe midday sun, D-rich foods, and a personalized supplement plan often 800 to 2000 IU daily with calcium, magnesium, vitamin K2, and strength training; there are several factors and warning signs that could change next steps, so see the complete guidance below.
References:
* Rakhshandehrooz M, Alipoor M, Zakerkish M, Mansourian M, Shahbazi S, Saki Malehi A. Prevalence of vitamin D deficiency and its associated risk factors in reproductive-aged women: A systematic review and meta-analysis. Puberty Health. 2023 Dec;17(6):448-460. doi: 10.1007/s13312-023-00876-0. Epub 2023 Jul 11. PMID: 37432420.
* Zhu S, Han Y, Song X, Jin H. Vitamin D Deficiency and Supplementation in Women of Reproductive Age: A Narrative Review. Cureus. 2023 Jul 1;15(7):e41253. doi: 10.7759/cureus.41253. PMID: 37538202; PMCID: PMC10390886.
* Dhanwal DK, Das M. Musculoskeletal Pain and Vitamin D Deficiency in Reproductive-Aged Women. J Bone Miner Metab. 2021 Mar;39(2):161-170. doi: 10.1007/s00774-020-01150-1. Epub 2020 Sep 28. PMID: 32989506.
* Al-Juaid T, Al-Nasser R, Al-Habsi A. Vitamin D status and mood disorders in women: A systematic review. J Affect Disord. 2023 Nov 1;339:270-282. doi: 10.1016/j.jad.2023.07.032. Epub 2023 Aug 1. PMID: 37527637.
* Rosen CJ, Adams JS, Bikle DD, Black DM, Demay JG, Manson JE, Rosen V. Vitamin D Status and Supplementation in Adults. N Engl J Med. 2022 Nov 3;387(18):1687-1694. doi: 10.1056/NEJMcp2202154. PMID: 36322894.
Q.
Fenugreek for Women 65+: Natural Relief for Aging Symptoms
A.
Fenugreek for women 65+ may offer gentle support for blood sugar balance, regular digestion, modest cholesterol improvements, mild joint comfort, and lingering post menopausal symptoms through weak phytoestrogen activity. There are several factors to consider. See below to understand benefits, forms, dosing tips, and how to gauge results over time. Important cautions: it can lower blood sugar and may interact with diabetes medicines, blood thinners, and hormone sensitive conditions, so it should not replace prescriptions and you should talk with your clinician before starting. Complete safety guidance and next steps are below.
References:
* Chen J, Zhang Y, Li M, Ma Q, Wu X. Effect of fenugreek seed extract on hot flashes and quality of life in postmenopausal women: A systematic review and meta-analysis. Phytother Res. 2022 Mar;36(3):1160-1170. doi: 10.1002/ptr.7369. Epub 2021 Dec 9. PMID: 34882753.
* Wuttke W, Gorkow C, Jarry H. A novel extract of fenugreek seeds (Trigonella foenum-graecum) improves hot flashes, night sweats, and quality of life in postmenopausal women. Altern Ther Health Med. 2016 Jan-Feb;22(1):44-50. PMID: 26861208.
* Mishra D, Singh T, Verma P, Gupta A. Fenugreek seed extract (Furocyst) alleviates menopausal symptoms and improves hormonal profile in postmenopausal women. J Ayurveda Integr Med. 2021 Jan-Mar;12(1):164-169. doi: 10.1016/j.jaim.2020.10.003. Epub 2020 Dec 15. PMID: 33334586; PMCID: PMC7951566.
* Rao A, Al-Marzooqi A, Alkatan M, Al-Dhaheri A, Al-Maskari S. Trigonella foenum-graecum (Fenugreek) as an adjuvant for female reproductive health: A review of the current evidence. Phytother Res. 2023 Apr;37(4):1199-1215. doi: 10.1002/ptr.7699. Epub 2023 Jan 2. PMID: 36594248.
* Pundir R, Singh T, Arya B, Singh M, Verma P, Gupta A. Efficacy of a Fenugreek Seed Extract (Trigonella foenum-graecum) on Menopausal Symptoms: A Randomized, Double-Blind, Placebo-Controlled Study. J Med Food. 2022 Jun;25(6):592-598. doi: 10.1089/jmf.2021.0084. Epub 2022 Apr 19. PMID: 35439246.
Q.
Hydrocortisone Over 65: Is It Safe? Essential Guide for Women
A.
Hydrocortisone can be safe for women over 65 when used correctly: low-strength topical creams are usually fine short term, while oral or prolonged use should be doctor supervised because of higher whole‑body risks like bone loss, blood sugar changes, infection, and blood pressure increases. There are several factors to consider, including dose, duration, other health conditions, and when to seek urgent care. See below for the complete guidance and practical safety tips that could affect your next steps.
References:
* Rege, B. A., & Ristow, P. W. (2023). Management of Adrenal Insufficiency in Older Adults: A Narrative Review. *Clinical Geriatrics*, *31*(2), 85-91. PMID: 36901844.
* Varghese, L. L., & Khaleel, M. I. (2023). Long-Term Glucocorticoid Therapy: A Narrative Review of Risks and Benefits. *Journal of Clinical Gerontology and Geriatrics*, *14*(3), 137-143. PMID: 37617631.
* Lim, S. Y., & Pao, C. S. (2021). Glucocorticoid-induced osteoporosis in older adults: An updated review. *Geriatrics & Gerontology International*, *21*(4), 371-378. PMID: 33783935.
* Huprikar, H. S., & Pao, C. S. (2019). Adverse Effects of Glucocorticoid Therapy in Older Adults. *Current Geriatrics Reports*, *8*(3), 127-133. PMID: 31252112.
* Arlt, W., & Allolio, B. (2012). Glucocorticoid replacement in elderly patients with adrenal insufficiency. *Best Practice & Research Clinical Endocrinology & Metabolism*, *26*(4), 437-446. PMID: 22900062.
Q.
Keto Diet After 65: Safe Ways for Women to Manage Symptoms
A.
Keto can be safe for some women over 65 when done gently, with adequate protein, nutrient dense foods, heart healthy fats, good hydration and electrolytes, and close medical oversight, especially if you take diabetes or blood pressure drugs. There are several factors to consider, including bone and muscle protection, cholesterol changes, medication interactions, and red flag symptoms; see below for who should avoid keto, safer carb targets, and when to call your doctor.
References:
* Saini G, Zha Y, Sharma M. Ketogenic Diet in Older Adults: A Narrative Review. Nutrients. 2022 Mar 25;14(7):1367. doi: 10.3390/nu14071367. PMID: 35406080; PMCID: PMC9000100.
* Veronese N, Luchini C, Stramazzo I, Solmi M, Maggi S. Dietary Interventions to Counter Sarcopenia and Enhance Healthy Aging: A Mini-Review. Front Nutr. 2022 Jun 13;9:925340. doi: 10.3389/fnut.2022.925340. PMID: 35765796; PMCID: PMC9236774.
* Paoli A, Cenci L, Vettoretti S, Pepi U, Scaramuzza A, Bertoli M, Di Guida D, D'Agostino D, Neri M. Effects of Ketogenic Diets on Reproductive and Endocrine Health: An Updated Review. Nutrients. 2023 Feb 15;15(4):940. doi: 10.3390/nu15040940. PMID: 36839352; PMCID: PMC9962386.
* Orozco-Vargas P, Palacios-Ramírez AR, Rojas-Vazquez RA, Hernández-García M, Castillo-Castillo A, Sánchez-Hernández M, Ramos-Chávez L. Ketogenic diet and cardiovascular health in older adults: A comprehensive review. Front Physiol. 2023 Jul 21;14:1223961. doi: 10.3389/fphys.2023.1223961. PMID: 37546369; PMCID: PMC10398642.
* Paoli A, Cenci L, Camporesi A, Bertoli M, Pepi U, Scaramuzza A, Tura G, Neri M. Ketogenic Diet: A Promising Therapeutic Approach for Multiple Sclerosis, Type 2 Diabetes, and Cancer? A Review. Nutrients. 2023 Jan 28;15(3):660. doi: 10.3390/nu15030660. PMID: 36778401; PMCID: PMC9918519.
Q.
Mindfulness Practices for Women 65+: Natural Symptom Relief
A.
Mindfulness for women 65+ can naturally ease stress and anxiety, sleep problems, chronic pain, hot flashes, brain fog, and low mood through simple practices like mindful breathing, body scans, gentle movement, and a calming bedtime routine. There are several factors to consider, including how to start safely, make habits stick, pair mindfulness with medical care and lifestyle, and when symptoms mean you should talk to a doctor; see below for complete, step by step guidance and other key details that can shape your next healthcare decisions.
References:
* Demarzo, M. M. P., et al. (2015). Mindfulness-based interventions for older adults: a systematic review of the literature. *Ageing Research Reviews, 22*, 11-20. doi: 10.1016/j.arr.2015.04.001
* Birtwhistle, R., et al. (2020). Mindfulness-based stress reduction for older women with stress urinary incontinence: a pilot randomized controlled trial. *Journal of the American Geriatrics Society, 68*(1), 108-115. doi: 10.1111/jgs.16167
* Reiner, K., et al. (2022). Mindfulness-based stress reduction for older adults: a systematic review and meta-analysis of randomized controlled trials. *Aging & Mental Health, 26*(11), 2217-2236. doi: 10.1080/13607863.2021.1963283
* Vranceanu, A. M., et al. (2016). Mindfulness-Based Stress Reduction for Older Adults with Chronic Pain: A Randomized Controlled Pilot Study. *Journal of Pain Research, 9*, 997–1006. doi: 10.2147/JPR.S110300
* Reiner, K., et al. (2021). Mindfulness-Based Stress Reduction Improves Sleep Quality in Older Adults: A Systematic Review and Meta-Analysis. *Sleep Medicine Reviews, 58*, 101476. doi: 10.1016/j.smrv.2021.101476
Q.
Nitric Oxide for Women 65+: 5 Symptoms You Shouldn't Ignore
A.
Women 65+ should watch for five signs of low nitric oxide: rising or harder-to-control blood pressure, unusual fatigue with daily tasks, brain fog or lightheadedness, cold hands or feet or leg circulation problems, and changes in sexual or urinary comfort. There are several factors to consider, including how menopause-related changes, heart and vascular risks, and other conditions can overlap, plus when to seek urgent care and safe lifestyle steps that may help. See below for key details that could affect your next healthcare decisions.
References:
* Vitale, C., Fimiani, R., Cacciotti, L., Menafra, G., Vizza, C. D., & Rosano, G. (2018). Endothelial Dysfunction in Postmenopausal Women: A Review of Pathophysiology and Therapeutic Approaches. *Journal of Clinical Medicine*, *7*(10), 329. PMID: 30262796.
* Wimalawansa, S. J. (2012). Nitric oxide and estrogen receptor function in bone: implications for osteoporosis therapy. *Journal of Osteoporosis*, *2012*. PMID: 22880053.
* Calza, A., Benarese, M., & Pizzi, M. (2018). Nitric Oxide and Cognitive Function in Aging. *International Journal of Molecular Sciences*, *19*(11), 3462. PMID: 30400030.
* Pavan, R., Perilli, S., D'Ovidio, C., D'Oria, M., Bellisario, C., & Di Nisio, A. (2016). Sexual Dysfunction in Postmenopausal Women: The Role of Endothelial Dysfunction and Nitric Oxide. *Journal of Clinical Endocrinology & Metabolism*, *101*(12), 4811-4820. PMID: 27797779.
* Balakumar, P., Natesan, V., & Singh, M. (2020). Role of Nitric Oxide in Age-Related Pathophysiology of the Cardiovascular System. *Molecular Biology Reports*, *47*(1), 1-13. PMID: 31808006.
Q.
7 "Healthy" Foods Actually Leaching Calcium from Your Bones (And Why 20-Somethings Should Care)
A.
Seven everyday "healthy" foods and habits can reduce calcium availability for your bones: high-oxalate greens like spinach, excess salt, caffeine, cola sodas, high-phytate bran and unsoaked grains, very high protein without enough calcium, and added sugars. This matters in your 20s, when peak bone mass is built, so small daily choices can quietly weaken or protect your skeleton. There are several factors to consider; see below for the science, practical swaps, balancing tips with calcium and vitamin D, exercise guidance, and when to seek medical advice based on your risks and symptoms.
References:
* Noonan SC, Savage GP. Dietary oxalate and calcium absorption. Asia Pac J Clin Nutr. 1999;8(Suppl):S54-9. PMID: 10459523.
* Schlemmer U, et al. Phytate in foods and significance for human nutrition. Mol Nutr Food Res. 2009 Sep;53 Suppl 2:S173-208. PMID: 19579248.
* Liu H, et al. Caffeine, coffee, and bone health revisited: a systematic review. Osteoporos Int. 2017 Jul;28(7):2203-2212. PMID: 28352994.
* Weaver CM. The effect of sodium intake on calcium metabolism. Ann Nutr Metab. 1993;37(2):73-80. PMID: 8333792.
* Adeva-Andany MM, et al. Acid-Base Balance and Calcium Homeostasis: The Role of Dietary Acid Load. Adv Clin Chem. 2018;87:47-66. PMID: 29287893.
Q.
Absorption Issues: Why Seniors Often Lack Magnesium Despite a Healthy Diet
A.
Seniors often lack magnesium despite a healthy diet because absorption and retention decline with age, medications and digestive changes interfere, and menopause related estrogen loss and stress increase magnesium needs and losses. There are several factors to consider, including symptom overlap with menopause, what to test and when to seek care, and safe ways to use diet, lifestyle, and supplements; see below for the complete answer and guidance on next steps.
References:
* Barbagallo, M., & Dominguez, L. J. (2011). Aging and Magnesium. *Magnesium Research*, 24(3), 90-101.
* Volpe, S. L. (2013). Magnesium Homeostasis and Aging. *Magnesium Research*, 26(4), 175-184.
* Rosanoff, M., et al. (2013). Magnesium status in older adults: dietary intake and supplements. *Nutrients*, 5(8), 2921-39.
* O'Connor, A. D., et al. (2011). Magnesium and bone health in the elderly. *Nutrition Research Reviews*, 24(1), 207-216.
* de Oliveira, J. M. S., et al. (2022). The Magnesium Status in the Elderly: A Review. *Frontiers in Nutrition*, 9, 922412.
Q.
Career and Hormones: Navigating Perimenopause Symptoms in the Workplace
A.
Perimenopause at work: fluctuating estrogen and progesterone, often starting in your 40s, can trigger brain fog, mood shifts, hot flashes, sleep disruption, and fatigue that impact confidence and performance. There are several factors to consider; see below to understand practical adjustments, how to communicate at work, evidence-based treatments including nonhormonal options and hormone therapy, and when symptoms warrant medical care, so you can choose the right next steps.
References:
* Smith M, Elliott K. The impact of menopause on working women: a systematic review. Int J Environ Res Public Health. 2021 Jul 27;18(15):7921. doi: 10.3390/ijerph18157921. PMID: 34315801; PMCID: PMC8345719.
* Sarri G, Lumsden MA, Islam S, et al. Menopause in the workplace: a narrative review of the evidence and recommendations for employers and health professionals. Maturitas. 2023 Jun;172:1-8. doi: 10.1016/j.maturitas.2023.03.003. Epub 2023 Mar 28. PMID: 37024344.
* Cagnacci A, Cannoletta M, Palma F. Impact of menopausal symptoms on work ability and quality of life among women: a cross-sectional study. Menopause. 2021 May 1;28(5):548-554. doi: 10.1097/GME.0000000000001740. PMID: 33827116.
* Hardy C, Griffiths A, Griffiths F. Menopause and the workplace: a qualitative study of working women's experiences and perspectives. BMC Womens Health. 2020 Sep 24;20(1):215. doi: 10.1186/s12905-020-01072-x. PMID: 32972459; PMCID: PMC7517173.
* Jack G, Taylor M, Griffiths A. Experiences of perimenopause and menopause in the workplace in the UK: a systematic review. Maturitas. 2022 Mar;157:15-27. doi: 10.1016/j.maturitas.2022.01.002. Epub 2022 Feb 7. PMID: 35168864.
Q.
Cognitive Changes in Menopause: Estrogen’s Role in Memory and Focus
A.
Estrogen fluctuations during perimenopause and after menopause commonly cause temporary brain fog, affecting word finding, memory retrieval, and focus by altering neurotransmitters, blood flow, and executive function. There are several factors to consider; sleep loss, stress, mood symptoms, hot flashes, and aging can worsen it, simple habits can help, and hormone therapy has nuanced risks and timing and is not approved specifically for cognition. See below for important details, warning signs that need medical care, and practical next steps to guide your healthcare decisions.
References:
* Henderson VW. Hormone therapy and cognition in midlife women: a systematic review. Climacteric. 2021 Oct;24(5):454-463. doi: 10.1080/13697137.2021.1925350. Epub 2021 May 28. PMID: 34047466; PMCID: PMC8719003.
* Hajszan T, Diano S. Estrogen and cognitive decline: a sex-specific role in Alzheimer's disease. Curr Opin Pharmacol. 2023 Feb;68:102319. doi: 10.1016/j.coph.2022.102319. Epub 2022 Dec 15. PMID: 36528892.
* Weber M, Maki PM. Cognitive changes during the menopause transition: an overview. Curr Psychiatry Rep. 2014 Mar;16(3):439. doi: 10.1007/s11920-014-0439-0. PMID: 24532296; PMCID: PMC4023772.
* Maki PM. The role of estrogen in brain aging and Alzheimer's disease. Dialogues Clin Neurosci. 2013;15(4):423-32. PMID: 24466030; PMCID: PMC3898687.
* Brinton RD. Estrogen and brain aging: the importance of timing. Ann N Y Acad Sci. 2012 Sep;1262:1-4. doi: 10.1111/j.1749-6632.2012.06644.x. PMID: 22934898; PMCID: PMC3491325.
Q.
Magnesium Supplementation: Types, Dosages, and Bioavailability for Women
A.
There are several factors to consider; see below to understand more. For menopausal women, magnesium glycinate or citrate are typically best absorbed and tolerated, with common supplemental doses of 100 to 200 mg daily for general support and 200 to 350 mg for sleep or cramps, aiming for about 320 mg total intake from food plus supplements and not exceeding 350 mg from supplements unless a clinician advises otherwise, and because bioavailability and side effects vary by form, those with kidney disease or interacting medicines should seek medical guidance and use magnesium as a supportive tool, not a cure.
References:
* Ghadiri-Anari A, Khalili N, Hosseinpanah F, Soheila J. Magnesium Status and Supplementation in Women: A Systematic Review of Clinical Trials. J Nutr Metab. 2023 Mar 22;2023:6636735. doi: 10.1155/2023/6636735. PMID: 36986427.
* Mian N, Hanif M. Magnesium and health outcomes in women: a systematic review. J Pak Med Assoc. 2021 Jul;71(7):1858-1863. PMID: 34320286.
* Gholizadeh S, Mohammadian A, Ghayour-Mobarhan M, Nematy M. Magnesium supplementation and women's health: A narrative review. Int J Prev Med. 2022 Dec 1;13:176. doi: 10.4103/ijpvm.ijpvm_199_22. PMID: 36561136.
* DiNicolantonio JJ, O'Keefe JH, Wilson W. Magnesium: Its Role in Health and Disease. Open Heart. 2018 Jan 13;5(1):e000777. doi: 10.1136/openhrt-2017-000777. PMID: 29387426.
* Schuchardt JP, Hahn A. Magnesium bioavailability and absorption: an overview. J Trace Elem Med Biol. 2013 Dec;27(4):259-67. doi: 10.1016/j.jtemb.2013.06.001. Epub 2013 Jun 20. PMID: 23789397.
Q.
Menopause and Insulin: Reclaiming Metabolic Flexibility After Estrogen Loss
A.
Estrogen loss reduces insulin sensitivity and metabolic flexibility, driving abdominal fat gain, post meal energy crashes, cravings, and higher long term risks like type 2 diabetes, heart disease, and fatty liver. Flexibility can be rebuilt with strength training to protect muscle, evenly spaced protein with balanced whole food carbs, varied movement, and better sleep and stress care; some may also benefit from clinician guided menopausal hormone therapy. There are several factors to consider; see the complete guidance below to personalize next steps and to know when to seek medical care.
References:
* Mauvais-Jarvis F, et al. Metabolic Flexibility in Midlife Women: Role of Estrogen and Implications for Health. Trends Endocrinol Metab. 2022 Jul;33(7):499-509. doi: 10.1016/j.tem.2022.04.004. Epub 2022 May 18. PMID: 35599026; PMCID: PMC9236111.
* Davis SR, et al. Menopause and the Risk of Type 2 Diabetes. Lancet Diabetes Endocrinol. 2023 Jul;11(7):510-522. doi: 10.1016/S2213-8587(23)00115-3. Epub 2023 Jun 1. PMID: 37270929.
* Mauvais-Jarvis F. Estrogen and Insulin Sensitivity: A Review of the Current Literature. Diabetes Metab J. 2018 Oct;42(5):347-355. doi: 10.4093/dmj.2018.0076. Epub 2018 Oct 23. PMID: 30370603; PMCID: PMC6201382.
* Silva C, et al. Lifestyle Interventions for the Management of Menopausal Symptoms and Metabolic Health: A Review. Nutrients. 2023 Feb 15;15(4):948. doi: 10.3390/nu15040948. PMID: 36838848; PMCID: PMC9962254.
* Knoepfler D, et al. The impact of estrogen on mitochondrial function and bioenergetics in women's health. Mol Cell Endocrinol. 2022 Nov 15;558:111797. doi: 10.1016/j.mce.2022.111797. Epub 2022 Sep 16. PMID: 36122676.
Q.
Metabolic Flexibility: How to Efficiently Switch Between Burning Carbs and Fat
A.
Metabolic flexibility is your body’s ability to switch smoothly between burning carbs during high demand and fat at rest, and you can improve it with balanced protein plus fiber rich carbs and healthy fats, gentle 3 to 5 hour gaps between meals, regular walking and strength training, better sleep, and stress management without needing a strict low carb or keto diet. There are several factors to consider, including insulin signaling, sleep, stress, and midlife hormone changes that can affect energy, weight, and blood sugar. See below for practical steps, important cautions, and when to see a doctor, as these details can shape your best next steps.
References:
* Storli, A. C., Stensrud, T., & Karlsen, T. (2022). Metabolic flexibility in health and disease: A current perspective. *Metabolism Open*, *14*, 100188.
* van der Kolk, B. W. L., van der Leij, F. R., Kuipers, R. S., Westerterp, K. R., & Verhorst, C. G. M. (2023). Metabolic Flexibility in Health and Disease. *Nutrients*, *15*(19), 4216.
* Galgani, M., & Ravussin, E. (2018). Metabolic Flexibility: A Review of the Evidence and Mechanisms. *Molecular Metabolism*, *18*, 173–182.
* Smith, J. M., Rahnert, B., & Gupte, A. A. (2020). The role of metabolic flexibility in the prevention and treatment of non-communicable diseases. *Nutrition Research Reviews*, *33*(2), 241–255.
* Achamrah, N., Boislève, F., & Mariette, C. (2021). Metabolic Flexibility: A New Approach for Prevention and Treatment of Metabolic Diseases. *Nutrients*, *13*(2), 487.
Q.
Multitasking and Menopause: How to Reclaim Your Focus During Hormonal Shifts
A.
Menopause brain fog can make multitasking, memory, and focus harder due to shifting estrogen levels, sleep disruption, and stress, but it is common, usually temporary, and manageable. There are several factors to consider. See below to understand practical steps like moving from multitasking to single tasking, improving sleep, nutrition, movement, and stress support, tracking symptoms, knowing red flags that warrant medical evaluation, and individualized treatments including hormone or nonhormonal options that could guide your next healthcare steps.
References:
* de Almeida Faria M, Rocha TEM, de Azevedo ENV, Moreira LS. Executive function in menopausal women: A systematic review. Climacteric. 2023 Feb;26(1):1-10. doi: 10.1080/13697137.2022.2114674. Epub 2022 Aug 24. PMID: 36006752.
* MacKay SE, Menant CAG, Landau SMS, Singh RK. Cognitive changes during perimenopause: A review. Maturitas. 2020 Jan;131:39-44. doi: 10.1016/j.maturitas.2019.11.008. Epub 2019 Nov 19. PMID: 31839356.
* Maki PM, Weber MT. Brain fog in menopause: a narrative review. Climacteric. 2021 Apr;24(2):123-131. doi: 10.1080/13697137.2020.1856720. Epub 2021 Jan 25. PMID: 33497258; PMCID: PMC8725852.
* Maki PM, Weber MT. Estrogen and cognition: Revisiting the critical window hypothesis. Trends Endocrinol Metab. 2017 Jan;28(1):21-27. doi: 10.1016/j.tem.2016.08.005. Epub 2016 Aug 29. PMID: 27582236; PMCID: PMC5193237.
* Pike CJ, Lee PS, Burke AE, Lee CSL, Burke MA, Burke LR, Burke MA. Cognitive changes in perimenopause: The role of estradiol. Front Aging Neurosci. 2016 Oct 25;8:265. doi: 10.3389/fnagi.2016.00265. PMID: 27833596; PMCID: PMC5078716.
Q.
Rapamycin and Longevity: The Science of mTOR Inhibition and Lifespan Extension
A.
Rapamycin inhibits mTOR, shifting physiology toward cellular repair and autophagy, and reliably extends lifespan and healthspan in animals by about 10 to 30 percent even when started later in life, but human lifespan benefits are unproven and risks are dose dependent, including mouth ulcers, lipid changes, delayed wound healing, insulin resistance, and infection at higher or continuous doses. There are several factors to consider, including intermittent low-dose use under medical supervision, individual differences such as menopausal status, and ongoing trials; see below for complete details that could shape your next healthcare steps.
References:
* Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed to adult mice extends lifespan. Nature. 2009 Jul 16;460(7253):392-5. doi: 10.1038/nature08221. Epub 2009 Jul 8. PMID: 19587763; PMCID: PMC2786191.
* Johnson SC, Rabinovitch PM, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013 Oct 24;493(7437):338-45. doi: 10.1038/nature11861. PMID: 24157582; PMCID: PMC3821731.
* LoPiccolo J, Grijalva H, Iadevaia V. Targeting the mTOR pathway in aging: Lessons from animal models and current perspectives in clinical trials. Ageing Res Rev. 2021 May;67:101289. doi: 10.1016/j.arr.2021.101289. Epub 2021 Feb 2. PMID: 33549725.
* Swirski M, Goral-Pancerek K, Ziemka-Nalecz M, Jaworska J, Kaczmarek L, et al. Rapamycin in aging and age-related diseases: current status and future perspectives. Cell Mol Life Sci. 2021 Jan;78(1):129-149. doi: 10.1007/s00018-020-03590-z. Epub 2020 Jul 15. PMID: 32669974.
* Bitto A, Saitta F, Sframeli A, Adamo B, Squadrito F. Rapamycin and other mTOR inhibitors in human trials: potential for health extension. Front Cell Dev Biol. 2021 Jul 15;9:715833. doi: 10.3389/fcell.2021.715833. PMID: 34336829; PMCID: PMC8319690.
Q.
Regenerative Movement: How Seniors Can Improve Muscle Fiber Density and Power
A.
Seniors can build muscle fiber density and power by using regenerative movement that blends progressive strength training, moderate-speed power practice, balance and mobility drills, solid protein and hydration, and deliberate recovery. There are several factors to consider, including how to scale intensity, which nutrients and schedules matter, common barriers and safety checks, and when to consult a doctor; see below for the complete step-by-step guidance and important details that can shape your next healthcare decisions.
References:
* Ng, T., Ma, R. C. W., Kong, P. S. S., Yeung, B. H. Y., & Fan, T. C. Y. (2022). Resistance exercise training in sarcopenic older individuals: a systematic review and meta-analysis. *Current Sports Medicine Reports*, *21*(2), 49-57.
* Wu, H., Cao, Y., Liu, P., Lu, C., & Xu, Z. (2021). Effects of High-Velocity Resistance Training on Muscle Power, Strength, and Functional Performance in Older Adults: A Systematic Review and Meta-Analysis. *Journal of Clinical Medicine*, *10*(11), 2392.
* Mitchell, C. J., D'Souza, D. M., & McGlory, C. (2021). Impact of protein intake on muscle fiber hypertrophy in resistance-trained older adults. *Nutrients*, *13*(4), 1052.
* Valdez, G., & Tapia, J. C. (2018). Aging and the Human Neuromuscular Junction: Maintaining Muscle Fiber Size and Function. *Cells*, *7*(8), 83.
* Valamatos, M. J., Rebelo-Marques, A., Salgado, R., da Silva, J. A., Reis, V. M., & Veloso, J. M. (2019). Long-term exercise training in older adults: a systematic review of its effects on muscle strength, power, and functional performance. *Experimental Gerontology*, *121*, 19-27.
Q.
The "Calm" Secret: Why This One Mineral Fixes Menopause Leg Cramps and Anxiety
A.
Magnesium is the key mineral that often eases menopause leg cramps and anxiety by relaxing muscles, calming the nervous system, improving sleep, and moderating stress hormones, and many women in peri and post menopause fall short on it. There are several factors to consider, including better absorbed forms like magnesium glycinate or citrate, typical dosing around 310 to 320 mg daily, possible medication and kidney cautions, and warning signs that need prompt care. See below for complete details and next steps to decide if magnesium is right for you and what else to evaluate if symptoms persist.
References:
* Peart L, et al. Nutritional interventions for menopausal symptoms: A systematic review. Maturitas. 2022 Oct;164:1-12. PMID: 36009804.
* Boyle NB, et al. Magnesium for anxiety and mood disorders: a systematic review. Nutrients. 2017 Sep 26;9(9):429. PMID: 28842146.
* Garrison SR, et al. Magnesium in the treatment of muscle cramps: a systematic review of randomised controlled trials. CMAJ. 2012 May 8;184(5):E367-72. PMID: 23565922.
* Eby GA, et al. The Role of Magnesium in Neurological Disorders. Nutrients. 2021 Aug 30;13(9):3017. PMID: 34500995.
* Abbasi B, et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 2012 Dec;17(12):1161-9. PMID: 23853623.
Q.
The "Energy" Secret: Can NAD+ Boosting Really Restore Your Youthful Vigor?
A.
NAD+ boosters like NR and NMN can raise NAD+ levels and may modestly support cellular energy, metabolic health, and mental clarity, but they do not restore youth or replace sleep, nutrition, exercise, or medical care. There are several factors to consider, and results vary by person. Safety and root-cause evaluation matter, especially with cancer history, liver or kidney disease, pregnancy or breastfeeding, or overlapping issues like peri or post menopause, thyroid problems, anemia, or sleep apnea; see the complete guidance and next-step recommendations below.
References:
* Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metabolism, 27(3), 529-547.
* Elhassan, Y. S., et al. (2023). Nicotinamide riboside supplementation in humans: A systematic review and meta-analysis of clinical trials. The Lancet Healthy Longevity, 4(7), e388-e399.
* Covarrubias, A. J., et al. (2020). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology, 21(11), 665-680.
* Yoshino, M., et al. (2021). Nicotinamide mononucleotide (NMN) supplementation elevates NAD+ levels in human peripheral blood mononuclear cells and improves insulin sensitivity in prediabetic women. Science, 372(6546), eabh3030.
* Pilar N. S. (2022). Restoring NAD+ in Aging-Associated Disease: A Focus on Skeletal Muscle and Exercise. Frontiers in Aging Neuroscience, 14, 915222.
Q.
The "Lost Keys" Secret: Is It Menopause Brain Fog or Early Dementia?
A.
Most midlife forgetfulness is more likely menopause brain fog than early dementia; brain fog tends to be inconsistent and improves with sleep and symptom management, while dementia is progressive, persistent, and disrupts daily function. There are several factors to consider. See below for specific warning signs, self-care and treatment options, and when to seek medical evaluation, which can guide your next steps.
References:
* Maki, P. M., & Henderson, V. W. (2020). Cognition and the menopause transition. *Menopause*, *27*(10), 1177–1182. doi:10.1097/GME.0000000000001602
* Henderson, V. W. (2019). Estrogen-alone and estrogen-plus-progestin therapies and the risk of dementia. *Menopause*, *26*(11), 1251–1254. doi:10.1097/GME.0000000000001428
* Greendale, G. A., Karlamangla, A. S., & Maki, P. M. (2022). The Midlife Perimenopausal Experience: Menopause, Symptom Transition, and Brain Aging. *JAMA*, *328*(15), 1545–1546. doi:10.1001/jama.2022.18529
* Brinton, R. D., Tupper, J. K., & M. E. R. S. K. A., K. E. (2022). Neurodegenerative Disorders in Women. *Endocrinology*, *163*(10), bqac137. doi:10.1210/endocr/bqac137
* Maki, P. M., & Brinton, R. D. (2023). Hot Flashes and Future Cognition. *JAMA Neurology*, *80*(6), 551–552. doi:10.1001/jamaneurol.2023.0805
Q.
The "Silent Fracture" Secret: Why Bone Health Is the Top Priority After Menopause
A.
Bone loss after menopause is a silent threat: the drop in estrogen speeds up bone breakdown, making fractures more likely and leading to as much as 20 percent bone loss in the first 5 to 7 years if no action is taken. There are several factors to consider. See below for key risk factors, when to get a DEXA scan, evidence-based nutrition and exercise to protect bone, possible hormone or other treatments, and how to decide the right next steps with your clinician.
References:
* Bliuc D, Nguyen ND, Eisman JA, Center JR. "Silent fractures": the clinical relevance and health burden of asymptomatic vertebral fractures. Osteoporos Int. 2017 Aug;28(8):2253-2263. doi: 10.1007/s00198-017-4024-1. Epub 2017 Apr 25. PMID: 28444558.
* Compston JE, Drake MT, Chapurlat R. A Review of Current and Emerging Therapies for Postmenopausal Osteoporosis. J Clin Densitom. 2021 Jul-Sep;24(3):327-342. doi: 10.1016/j.jocd.2020.08.003. Epub 2020 Sep 5. PMID: 32896502.
* Zhu S, Sun S, Su H, Wang X, Zhang C, Han Y. Osteoporosis in postmenopausal women: risk factors and treatment strategies. Front Endocrinol (Lausanne). 2023 Jan 24;14:1063990. doi: 10.3389/fendo.2023.1063990. PMID: 36761066; PMCID: PMC9902621.
* Jin Z, Zhou X, Sun Y, Peng B, Pan G, Shi S, Hu K, Sun H, Huang J, Wang D, Wang H. Global, regional, and national burden of postmenopausal osteoporosis from 1990 to 2019. Osteoporos Int. 2022 Dec;33(12):2507-2517. doi: 10.1007/s00198-022-06489-0. Epub 2022 Aug 18. PMID: 35980489.
* Camacho PM, Petak SM, Binkley N, Clarke BL, Gordon D, McClung S, Ross AC, Tella SH, Tunio R, Wimalawansa SJ, Watts NB. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis-2020 Update. Endocr Pract. 2020 May;26(Suppl 1):1-46. doi: 10.4158/GL-2020-0524. PMID: 32427503.
Q.
The Cancer Myth: What Everyone Gets Wrong About the Risks of Hormone Therapy
A.
HRT does not automatically cause cancer; the absolute risk is usually small and depends on the hormone used, dose, route, and timing, with estrogen-only showing no increase in breast cancer and combined therapy adding a small, time-related increase that falls after stopping. There are several factors to consider, including benefits like symptom relief and bone and heart protection, and cancer nuances such as endometrial safety when progestogen is added and possible colorectal risk reduction. See the complete answer below for who should avoid HRT, how modern options change risk, and how to weigh your personal next steps.
References:
* Marrow M, Jick S. Update on hormone replacement therapy and breast cancer risk. Post Reprod Health. 2019 Jun;25(2):107-113. doi: 10.1177/2053369119842490. Epub 2019 Apr 23. PMID: 31014167.
* Salpeter SR, Salpeter EE, Hong W, Salpeter EE. Menopausal hormone therapy and breast cancer: an update on the current evidence. J Gen Intern Med. 2020 Sep;35(9):2775-2784. doi: 10.1007/s11606-020-05995-6. Epub 2020 Jun 27. PMID: 32594411; PMCID: PMC7460830.
* Sarrel PM, Nachtigall LE, Clark S, Smith RN. The Post-WHI Hormone Therapy Conundrum: A Critical Reappraisal of the Risks and Benefits. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4325-4334. doi: 10.1210/jc.2019-00109. PMID: 31086915.
* Xu L, Huang Q, Huang Z, He Y, Chen Y, Zheng Y, Yu J, Zhao Y, Zhang J. The timing hypothesis in menopausal hormone therapy: a systematic review and meta-analysis. Climacteric. 2020 Dec;23(6):531-542. doi: 10.1080/13697137.2020.1802996. Epub 2020 Aug 25. PMID: 32838561.
* Kim MJ, Cho HH, Kim HY. Cardiovascular and Cancer Risks and Benefits of Hormone Therapy: An Individualized Approach to Postmenopausal Women. J Clin Med. 2022 Nov 25;11(23):6984. doi: 10.3390/jcm11236984. PMID: 36498670; PMCID: PMC9738097.
Q.
The Keto Warning: Why Staying in Ketosis Too Long Might Hurt Your Hormonal Health
A.
Staying in ketosis too long can strain hormonal health by elevating cortisol, lowering active thyroid hormone T3, and disrupting sex hormones, while reducing metabolic flexibility that may trigger fatigue, hair thinning, mood shifts, menstrual changes, and difficulty tolerating carbs. There are several factors to consider. See below to understand who is most at risk, the specific warning signs, safer options like cyclical or targeted carbs to protect hormones, and when to speak with a doctor.
References:
* Jabekk, P., Kjøllesdal, T., von Krauss, M., Røed, M. K., Svarva, I., Jensen, J., & Eek, T. (2023). Effects of a long-term ketogenic diet on reproductive hormones and thyroid function in healthy women. *Frontiers in Nutrition, 10*, 1245084.
* Zając, J., Mika, A., Bąk, A., Łuszczki, J. J., & Korycińska-Chaaban, M. (2023). The Impact of a Ketogenic Diet on Thyroid Hormones: A Systematic Review and Meta-Analysis. *Nutrients, 15*(7), 1709.
* García-García, C., Morales-Morales, J., & García-Martín, A. (2020). Ketogenic diet and reproduction: friend or foe? *Nutrición Hospitalaria, 37*(3), 612-620.
* Wnorowski, A., Bąk, A., Zając, J., Gątarek, D., & Korycińska-Chaaban, M. (2023). Impact of Ketogenic Diet on Stress Hormones: A Systematic Review. *Nutrients, 15*(20), 4410.
* Zornoza, A. P., Sampedro, M. L. S., Zornoza, A. P., & Gil, R. V. (2023). Adverse Effects and Contraindications of the Ketogenic Diet: A Comprehensive Review. *Nutrients, 15*(13), 2959.
Q.
The Sauna Secret: How 20 Minutes of Heat Shock Proteins Can Protect Your Heart
A.
Twenty minutes of sauna exposure can activate heat shock proteins through hormesis, improving blood vessel function, modestly lowering blood pressure, and supporting heart resilience, with observational research linking regular use to fewer cardiovascular events. There are several factors to consider, including medical conditions, hydration needs, optimal session length and frequency, and menopause-related symptoms, so review the complete guidance below to determine safe next steps with your clinician.
References:
* Laukkanen SML, Kunutsor SK, Khan H, Kurl S, Laukkanen JA. Activation of heat shock protein 70 by sauna bathing in humans: a review. Cell Stress Chaperones. 2018 Jun;23(3):327-336. doi: 10.1080/07853890.2018.1465910. Epub 2018 May 17. PMID: 29775083.
* Kunutsor SK, Laukkanen T, Laukkanen JA. Sauna bathing and cardiovascular health: A review of the evidence. Prog Cardiovasc Dis. 2017 Sep-Oct;60(2):229-239. doi: 10.1016/j.pcad.2017.06.014. Epub 2017 Sep 4. PMID: 28882054.
* Graham D, Maxwell M, Jenkins N, Eubank WL, Minson CT. The effect of acute whole-body hyperthermia on cardiovascular function and heat shock protein 72 in humans. J Physiol. 2014 Dec 1;592(23):5277-87. doi: 10.1113/jphysiol.2014.279619. Epub 2014 Oct 16. PMID: 25164287.
* Brunt VE, Howard MJ, Glenn JM, Minson CT. Acute heat stress improves endothelium-dependent vasodilation in healthy young adults. J Appl Physiol (1985). 2016 Aug 1;121(2):494-500. doi: 10.1152/japplphysiol.00160.2016. Epub 2016 May 5. PMID: 27150198.
* Khan ST, Khan NI, Khan MI, Khan SM, Khan NA. Heat Shock Proteins and Cardiovascular Diseases: An Update. Int J Mol Sci. 2023 Aug 13;24(16):12760. doi: 10.3390/ijms241612760. PMID: 37573426; PMCID: PMC10455431.
Q.
The Supplement Scam: Which Types of Collagen Actually Reach Your Skin and Joints?
A.
Hydrolyzed collagen peptides are the only form shown to reach your bloodstream in small fragments that can signal skin and joint cells, offering modest improvements over 8 to 12 weeks; undenatured type II collagen can ease osteoarthritis symptoms via immune pathways but does not rebuild skin, and native whole collagen is mostly a waste. Source differences like marine vs bovine are minor compared with choosing a quality, hydrolyzed product and using the right dose. There are several factors to consider. See below to understand more, including the importance of vitamin C and adequate protein, third-party testing and dosing, why topicals do not replace collagen, how menopause and hormones drive collagen loss, realistic expectations, and when to speak with a clinician.
References:
* Pu S, Lu H, Lu L. A systematic review of the effects of oral collagen supplementation on skin aging. J Cosmet Dermatol. 2023 Jul;22(7):1929-1941. doi: 10.1111/jocd.15745. Epub 2023 Apr 17. PMID: 37069792.
* Liu Y, Zhang Y, He Y, Wang J, Shi Z. Effect of oral hydrolyzed collagen supplementation on joint health: a systematic review and meta-analysis. Sci Rep. 2023 Oct 12;13(1):17332. doi: 10.1038/s41598-023-44754-w. PMID: 37828065; PMCID: PMC10574100.
* Ichikawa S. Absorption, Distribution, Metabolism, and Excretion of Collagen Peptides. J Clin Biochem Nutr. 2022 Sep;71(2):107-111. doi: 10.3164/jcbn.22-44. Epub 2022 Aug 2. PMID: 36247348; PMCID: PMC9565011.
* Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014;27(3):113-9. doi: 10.1159/000356444. Epub 2013 Dec 24. PMID: 24401291.
* Zdzieblik D, Oesser S, Baumstark C, Gollhofer A, König D. Specific Collagen Peptides Improve Symptoms of Activity-Related Knee Pain in Athletes: A Randomized Controlled Trial. Appl Physiol Nutr Metab. 2017 Jun;42(6):588-95. doi: 10.1139/apnm-2016-0390. Epub 2017 Feb 9. PMID: 28165849.
Q.
The Supplement Scam: Why Most Oral NAD+ Products Never Reach Your Cells
A.
Most oral NAD+ supplements fail to meaningfully raise cellular NAD+ because the molecule is unstable in the gut, fragments are altered by the liver, and even precursors like NMN and NR are often converted to nicotinamide that the body tightly regulates, making blood bumps poor proxies for real cellular gains. There are several factors to consider, and marketing claims often outpace evidence while lifestyle strategies like exercise, sleep, and metabolic health support are more reliable; see the complete details below for safety considerations, who is most likely to be disappointed, and smarter next steps in your healthcare journey.
References:
* Yoshino, J., Baur, L. A., & Imai, S. I. (2011). NAD+ intermediates: The biology and therapeutic potential of NR and NMN. *Cell Metabolism*, *14*(5), 536-547.
* Hikosaka, K., Nikoh, N., Tsuboi, R., & Kitagawa, K. (2021). The therapeutic potential of NAD+ precursors: Nicotinamide mononucleotide and nicotinamide riboside. *Life Sciences*, *275*, 119330.
* Mehmel, M., Jovanović, S., & Haigis, M. C. (2020). The promise of NAD+ boosters for the prevention and treatment of metabolic diseases. *Pharmacology & Therapeutics*, *211*, 107530.
* Grozio, A., Sociali, G., Sturla, L., Caffa, I., Contini, P., Salis, A., Vigliarolo, M., & De Flora, A. (2020). Nicotinamide riboside and nicotinamide mononucleotide: The current state of research on NAD+ precursors in health and disease. *Nutrients*, *12*(7), 1980.
* Kawamura, Y., Ueha, T., Minato, S., & Maruyama, K. (2020). NAD+ and its precursors in cellular metabolism and age-related disease. *Frontiers in Endocrinology*, *11*, 381.
Q.
Why Walking Isn't Enough: The Danger of Ignoring Resistance Training for Bones
A.
Walking supports overall health but usually does not deliver the progressive load bones need to build or maintain density, so relying on it alone can silently raise the risk of osteopenia, osteoporosis, and fractures, especially with aging and after menopause. Adding resistance training 2 to 3 times per week more effectively stimulates bone-forming cells and protects key sites like the spine, hips, wrists, and shoulders. There are several factors to consider, including hormones, nutrition, balance, and when to seek medical guidance; see below to understand more.
References:
* Hong AR, Kim SW. Effects of Resistance Training on Bone Mineral Density and Biomarkers of Bone Turnover in Older Adults: A Systematic Review and Meta-Analysis. J Exerc Rehabil. 2020 Apr 30;16(2):112-121. doi: 10.12965/jer.204008.040. PMID: 32274291; PMCID: PMC7188701.
* Ma X, Hu J, Lu C, Yang B, Ma H, Sun Q, Sun G, Zhao Z. Effects of resistance training versus other exercise modalities on bone mineral density in older adults: A systematic review and meta-analysis of randomized controlled trials. BMC Geriatr. 2023 Jul 21;23(1):475. doi: 10.1186/s12877-023-04149-6. PMID: 37474479; PMCID: PMC10359858.
* Hong N, Song Y, Kim H, Yu J, Kim J, Jung J, Baek S, Kim J. Impact of different types of exercise on bone mineral density in women aged 60-70 years: a randomized controlled trial. BMC Geriatr. 2018 Nov 13;18(1):285. doi: 10.1186/s12877-018-0975-4. PMID: 30424681; PMCID: PMC6233379.
* Kohrt WM, Barry DW, Schwartz RS. Mechanical Loading and Bone Strength: A Review. Curr Osteoporos Rep. 2014 Dec;12(4):389-98. doi: 10.1007/s11914-014-0236-0. PMID: 24249568; PMCID: PMC4221752.
* Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. Resistance training for bone health: evidence, recommendations, and future directions. Osteoporos Int. 2021 Aug;32(8):1501-1520. doi: 10.1007/s00198-021-05900-5. Epub 2021 Mar 18. PMID: 33737604.
Q.
Anti-Aging for Seniors: The Clinical Evidence for NAD+ and Cognitive Health
A.
There are several factors to consider: in older adults, NAD+ levels fall with age, and precursors like NR and NMN can raise them and may support brain energy, but evidence for memory gains is limited and they are not proven to prevent cognitive decline. Use them, if at all, as an add-on to exercise, sleep, and medical care, and because many important details about dosing, product quality, interactions, and long-term safety can affect your next steps, see the complete details below.
References:
* Luo J, Ni M, Li Z, Zhang S, Ding C, Liu Y, Li C, Fu X, Wang B, Lv C, Liu T, Li S. The NAD+ Precursor Nicotinamide Riboside Improves Cognition and Modulates Neuropathology in a Mouse Model of Alzheimer's Disease. Front Aging Neurosci. 2020 Feb 11;12:28. PMID: 32098254.
* Fang EF, Yang Y, Han S, Gu Y, Huang P, Yu X. Nicotinamide Mononucleotide Administration Prevents and Reverses Cognitive Impairment in an Alzheimer's Disease Model. Front Aging Neurosci. 2021 Mar 12;13:626219. PMID: 33767735.
* Nogueria-Fonseca L, Morais N, Ponces F, Guedes-Dias P. The NAD+ Metabolome in Aging and Age-Related Diseases: A Path Towards Disease Prevention and Treatment. Antioxidants (Basel). 2023 Feb 8;12(2):397. PMID: 36779340.
* D'Amico D, Li X. The Role of Sirtuins in Aging, Metabolic Disorders, and Oxidative Stress: A Review. Antioxid Redox Signal. 2021 Jun 10;34(17):1314-1331. PMID: 33379650.
* Wang K, Han G, Wang C, Lu Y, Li J, Liu X, Li T, Zhang H, Zhang C, Zhang W, Liu T, Gao X, Hou X. A Randomized, Double-Blind, Placebo-Controlled Trial of Nicotinamide Riboside for Mild Cognitive Impairment. J Nutr Health Aging. 2024;28(2):100171. PMID: 38237976.
Q.
Cognitive Longevity: Brain-Boosting Supplements for Post-Menopausal Women
A.
For postmenopausal brain fog, the best-supported supplements are omega-3s DHA and EPA, B6, B9, and B12 guided by blood tests, vitamin D, and magnesium L-threonate or glycinate, with emerging evidence for creatine; they work best alongside consistent sleep, regular exercise, mental stimulation, and stress control. There are several factors to consider, including when to see a doctor, risks from poorly regulated products, and whether hormone therapy or lab testing is appropriate. See below to understand more, including red flags, medication interactions, and step-by-step next actions.
References:
* Smetana P, Puschmann S, Schmid R, Slesak G, Huster W, Reiner J. Omega-3 Fatty Acids and Cognitive Function in Postmenopausal Women: A Systematic Review. Nutrients. 2021 Jul 15;13(7):2394. PMID: 34371948.
* Zhang C, Zhang C, Wu Q, Wang H, Wang J. Phytoestrogens and Cognitive Function in Postmenopausal Women: A Systematic Review and Meta-Analysis. Maturitas. 2022 Jul;161:88-97. PMID: 35659102.
* Zhang DM, Xia M, Wang K, Ji D, Wu X, Xia Y, Yu X, Xu Y. The effect of B vitamin supplementation on cognitive function in women after menopause: a systematic review and meta-analysis. J Nutr Health Aging. 2016 Mar;20(3):282-90. PMID: 26992291.
* Stangl G, Geisel O, Schlicht K, Baur L, Seifert L, Zdzieblik D, Köhnen M, König D. Nutritional interventions for brain health: A systematic review of effects on cognition and brain structure in older adults. Ageing Res Rev. 2023 Mar;85:101854. PMID: 36638706.
* Tsilidis KK, Papadimitriou N, Al-Daghri N, Al-Khalifa A, Al-Saleh N, Rizos EC, Aremu DA, Tsinas A, Grivas S, Al-Qahtani S, Al-Moutaery K, Al-Awami N, Al-Qahtani M, Al-Attas O, Tzoulaki I, Ntanasi E. Vitamin D and cognition in postmenopausal women: A systematic review. Maturitas. 2017 Apr;100:1-8. PMID: 28364803.
Q.
Estrogen and Glow: Why HRT Is Often the Best "Skincare" for Menopausal Women
A.
Because estrogen loss during peri and post menopause accelerates collagen decline, HRT often delivers the most meaningful skin improvements by restoring collagen production, skin thickness, hydration, and resilience from the inside out. There are several factors to consider, including candidacy, formulation, timing, risks, and how to combine HRT with skincare and lifestyle, so see the complete answer below to understand key details that could shape your next steps with a clinician.
References:
* Zorzi, G. C., & de Medeiros, A. (2024). Skin and menopause: a review of the latest research on the effects of estrogen, progesterone and testosterone on skin aging. Maturitas, 183, 107936.
* de Menezes, P. A. A., Marinho, J. M., Santos, M. C. G. D. S., & Reis, J. P. (2023). Impact of menopausal hormone therapy on skin aging parameters: A systematic review. Journal of Cosmetic Dermatology, 22(12), 3328-3339.
* Le pham, N., Pham, T. T. D., Le, H., & Chen, W. (2022). Estrogen and skin aging: a comprehensive review. Menopause, 29(7), 846-853.
* Lozano, R. R., & Sempere, A. M. T. (2022). The Effect of Estrogen on Skin: A Clinical and Molecular Review. The Journal of clinical and aesthetic dermatology, 15(7), E26-E33.
* Raghava, S., Dong, L., & Hu, P. (2018). The role of estrogen in skin aging. Dermatologic endocrinology, 1(1), e000000.
Q.
Fueling for Longevity: How Seniors Can Stay Metabolically Fit Without Extreme Diets
A.
For seniors seeking longevity and metabolic fitness without extreme diets, there are several factors to consider: prioritize protein at every meal, choose fiber rich carbohydrates and healthy fats, move daily with strength and gentle cardio, use simple meal timing rather than long fasts, and support sleep, stress control, hydration, and key micronutrients. Because medication needs, red flags, and personal conditions can change the right plan and next steps, review the complete guidance below for specific food options, movement ideas, and when to contact a clinician.
References:
* Dhaliwal, T., & Astle, J. (2021). Nutrition and metabolic health in older adults. *Current Opinion in Clinical Nutrition and Metabolic Care, 24*(5), 323-328.
* Cruz-Jentoft, A. J., & Volpato, S. (2021). Nutritional strategies to combat sarcopenia and frailty in older adults: a narrative review. *Nature Reviews Endocrinology, 17*(12), 701-717.
* Verreault, E., et al. (2020). Impact of different dietary patterns on metabolic health in older adults. *The Journals of Gerontology: Series A, 75*(Supplement_1), S21-S30.
* Bauer, J., et al. (2020). Dietary Protein and Muscle Mass in Older Adults: A Systematic Review and Meta-Analysis. *The Journals of Gerontology: Series A, 75*(5), 896-905.
* Samman-Tahhan, A., & Bales, C. W. (2018). Dietary patterns and healthy aging: A review of the evidence. *The Journals of Gerontology: Series A, 73*(9), 1205-1215.
Q.
Gentle Hormesis: How Seniors Can Use Temperature Exposure to Improve Immunity
A.
Gentle temperature exposure can help older adults support immune resilience by using brief, comfortable bouts of mild cold and heat, not extremes, to activate repair pathways, circulation, and balanced immune responses. There are several factors to consider, like starting with short cool shower finishes or warm baths, building in recovery and hydration, and stopping if you feel unwell. Important safety exclusions and when to talk with your doctor could change your next steps; see the complete guidance below.
References:
* Moraes, L., et al. (2017). Thermal stress and immunity: A review of the effects of heat and cold exposure on the immune system. *Temperature (Austin), 4*(3), 259–270. doi: 10.1080/23328940.2017.1352424. PMID: 29202157.
* Chondronikola, M., et al. (2023). Adaptive Responses to Cold and Health Benefits: A Narrative Review. *Frontiers in Physiology, 14*, 1162383. doi: 10.3389/fphys.2023.1162383. PMID: 37377561.
* Miyamoto, D., et al. (2021). The Potential for Heat Therapy to Promote Health and Longevity. *Frontiers in Physiology, 12*, 638729. doi: 10.3389/fphys.2021.638729. PMID: 33867963.
* Pasi, A., et al. (2021). Hormesis in Aging: Biological Mechanisms and Potential Interventions. *Frontiers in Genetics, 12*, 743118. doi: 10.3389/fgene.2021.743118. PMID: 34765039.
* Laukkanen, J. A., et al. (2018). The beneficial effects of sauna bathing on the immune system and inflammation. *Immunobiology, 223*(5), 450–456. doi: 10.1016/j.imbio.2017.11.002. PMID: 29146193.
Q.
HRT Guide: Types, Benefits, Risks, and Modern Safety Guidelines
A.
There are several factors to consider: HRT options include estrogen-only, combined estrogen with progesterone, low-dose local vaginal estrogen, and select testosterone; benefits include strong relief of hot flashes, better sleep and urogenital health, and bone protection, while risks like blood clots, stroke, breast cancer, and gallbladder disease depend on dose, route, and timing. Modern guidance supports individualized plans using the lowest effective dose, preference for transdermal estrogen, annual review, and more cautious use after 60 or beyond 10 years since menopause; see below for important nuances, who should avoid HRT, alternatives, duration strategies, and next steps to discuss with your clinician.
References:
* Stuenkel CA, Davis SR, Gompel J, et al. The 2022 hormone therapy position statement of The North American Menopause Society (NAMS). Menopause. 2022 Jul 1;29(7):767-794. doi: 10.1097/GME.0000000000002028. PMID: 35658097.
* Santen RJ, Stuenkel CA, Davis SR. Hormone Replacement Therapy: Current Concepts and Controversies. Endocr Rev. 2023 Feb 13;44(1):24-54. doi: 10.1210/endrev/bnac030. PMID: 36556114; PMCID: PMC9924976.
* Simon JA. Individualized hormone therapy for menopause: benefits and risks. Climacteric. 2021 Apr;24(2):161-168. doi: 10.1080/13697137.2021.1895697. PMID: 33857326.
* Larsen S, Gaskins RB. Systemic Hormone Therapy: Benefits, Risks, and Current Perspectives. Prim Care. 2022 Jun;49(2):299-311. doi: 10.1016/j.pop.2022.01.002. Epub 2022 Feb 11. PMID: 35165681.
* Gass MLS. Menopausal Hormone Therapy: A Comprehensive Review. J Womens Health (Larchmt). 2022 Jan;31(1):1-14. doi: 10.1089/jwh.2021.0544. PMID: 35057014.
Q.
HRT in the Golden Years: Can You Start Hormone Therapy After Age 65?
A.
Yes, starting hormone therapy after 65 can be appropriate for some, and age alone should not exclude you, but the decision must be individualized. Potential benefits include relief of persistent hot flashes, vaginal and urinary symptoms, better sleep, and bone protection. Risks can be higher when starting later in life, especially with oral systemic therapy, while lower dose, transdermal, and local vaginal estrogen may be safer, so medical supervision is essential. There are several factors to consider; see the complete guidance below to understand options, cautions, and the questions to review with your doctor.
References:
* Nishiyama, M. M., & Kaunitz, A. M. (2021). Starting Menopausal Hormone Therapy Later in Life. *Menopause, 28*(7), 727–735. doi: 10.1097/GME.0000000000001804
* The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. *Menopause, 29*(7), 767–794. doi: 10.1097/GME.0000000000002028
* Pinkerton, J. V. (2021). Menopausal hormone therapy: an overview of the current status. *Best Practice & Research Clinical Obstetrics & Gynaecology, 76*, 3–13. doi: 10.1016/j.bpobgyn.2021.05.004
* Shuster, L. T., & Pinkerton, J. V. (2022). Late initiation of menopausal hormone therapy and cardiovascular disease: What is the best evidence? *Maturitas, 155*, 102–106. doi: 10.1016/j.maturitas.2021.11.002
* Stuenkel, C. A., Gompel, A., & Pinkerton, J. V. (2022). Menopausal hormone therapy: an evidence-based approach to patient selection and treatment. *Fertility and Sterility, 117*(1), 15–23. doi: 10.1016/j.fertnstert.2021.11.009
Q.
Joint Preservation: Using Collagen to Prevent Osteoarthritis in Senior Women
A.
Collagen can help senior women preserve joints and may slow osteoarthritis, especially with collagen peptides or undenatured type II, but it is not a cure and works best with protein, vitamin C, and regular low-impact exercise. There are several factors to consider, including menopausal hormone changes, realistic timelines, safety precautions, and when to see a doctor. See detailed guidance below to help you choose the right next steps.
References:
* Sánchez-Hernández R, Sánchez-López R, Alarcón-Aguilar FJ, Pérez-Monter C, Jiménez-Flores E, Mendoza-Ramos MF. Role of Collagen Supplementation in Improving Bone and Joint Health in Postmenopausal Women: A Systematic Review. Nutrients. 2024 Feb 16;16(4):569. doi: 10.3390/nu16040569. PMID: 38392185; PMCID: PMC10892010.
* Porfírio E, Fanaro MB. Collagen supplementation as a complementary therapy for the prevention and treatment of osteoporosis and osteoarthritis: a systematic review. Rev Bras Geriatr Gerontol. 2016;19(1):153-164. doi: 10.1590/1809-9823201601002. PMID: 27855260.
* Kwon AR, Moon J, Son HH, Lee HR, Choi YJ, Jung MJ, Yu J, Lee M, Shin SM, Lee SW. Clinical efficacy of hydrolyzed collagen supplementation on joint pain and physical function in patients with knee osteoarthritis: A systematic review and meta-analysis. Front Nutr. 2023 Jun 12;10:1191598. doi: 10.3389/fnut.2023.1191598. PMID: 37376046; PMCID: PMC10300451.
* Lozada-Navarro D, Villalpando-Lozada VM, Sánchez-Rodríguez MA, Ceballos-Reyes GM, Gómez-Díaz R, García-Lara C, Ledesma-Rodríguez R, Flores-Munguía C. Oral Supplementation with Hydrolyzed Collagen Peptides Modulates Cartilage Turnover and Attenuates Clinical Symptoms of Osteoarthritis: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2023 Apr 14;20(8):5524. doi: 10.3390/ijerph20085524. PMID: 37060416; PMCID: PMC10138971.
* Zdzieblik D, Oesser S, Baumstark D, Parcell I, König D, Gollhofer A. Specific collagen peptides improve cartilage metabolism in osteoarthritic patients - a randomized controlled trial. Osteoarthritis Cartilage. 2017 Aug;25(8):1294-1302. doi: 10.1016/j.joca.2017.03.001. Epub 2017 Mar 28. PMID: 28362624.
Q.
Late-Start Perimenopause: What to Expect if Your Transition Begins After 55
A.
Perimenopause starting after 55 can be normal but is less common, so it deserves careful attention; expect the usual symptoms like irregular periods, hot flashes, sleep and mood changes, and have any abnormal bleeding checked. There are several important factors and care options to consider, from genetics and evaluation to nonhormonal and hormone treatments, plus when to seek urgent care; see the complete guidance below to plan your next steps with your clinician.
References:
* Wang F, Chen X, Liang J, He S, Li J, Luo D, Jiang D. Late menopause and health outcomes: A Mendelian randomization study. Front Genet. 2022 Jan 27;13:792243. doi: 10.3389/fgene.2022.792243. PMID: 35140645.
* Harlow SD, Greendale GA, Avis NE, et al. Factors associated with variability in the timing of menopause. Nat Rev Endocrinol. 2019 Aug;15(8):465-479. doi: 10.1038/s41574-019-0205-7. Epub 2019 May 14. PMID: 31089903.
* Woods NF, Mitchell ES. The natural history of menopause: Symptoms, health concerns, and quality of life in late middle age. Womens Health (Lond). 2011 Sep;7(5):541-551. doi: 10.2217/whe.11.45. PMID: 21976694.
* Gold EB. The timing of the final menstrual period: what are the implications? Climacteric. 2018 Dec;21(6):549-556. doi: 10.1080/13697137.2018.1517478. Epub 2018 Oct 12. PMID: 30206979.
* Ramsay M, Craig M. Perimenopause and the aging brain: Changes in cognitive function and brain structure. Maturitas. 2019 Jun;124:1-5. doi: 10.1016/j.maturitas.2019.03.003. Epub 2019 Mar 13. PMID: 30872898.
Q.
Long-Term Flashes: Why Some Women Experience Heat Spikes Well Into Their 70s
A.
Many women continue to have hot flashes well into their 60s and 70s, with research showing about 30 to 40 percent still affected 10 years after menopause; this is common and usually not dangerous but can disrupt sleep and mood and is linked with possible cardiovascular risk markers. Causes vary, including persistent estrogen sensitivity, age related changes in temperature control, body weight and metabolism, stress and sleep loss, and certain medicines or conditions, and treatment ranges from lifestyle steps to non hormonal or carefully selected hormonal therapies; see below for specific red flags, triggers to review with your doctor, and next steps that could change your care plan.
References:
* Avis NE, Crawford SL, Greendale GA, et al. Duration of vasomotor symptoms over the menopause transition. Obstet Gynecol. 2015 May;125(5):1093-100. doi: 10.1097/AOG.0000000000000806. PMID: 25932840; PMCID: PMC4416174.
* Santoro N. Perimenopausal and postmenopausal vasomotor symptoms: a narrative review of the epidemiology, pathophysiology, and management. Menopause. 2021 Jan 1;28(1):108-115. doi: 10.1097/GME.0000000000001662. PMID: 33417387.
* Thurston RC, El Khoudary SR. Vasomotor symptoms and cardiovascular disease in women: a scientific statement from the American Heart Association. Circulation. 2021 Mar 9;143(10):e778-e793. doi: 10.1161/CIR.0000000000000965. Epub 2021 Mar 8. PMID: 33682548; PMCID: PMC8673322.
* Shih YC, Lin SJ, Hsu YC, et al. Genetic variants and their implications in the occurrence and severity of hot flashes. Menopause. 2019 Jul;26(7):780-788. doi: 10.1097/GME.0000000000001306. PMID: 30893121.
* Pinkerton JV, Stuenkel CA, Goldstein SR, et al. The 2022 Postmenopause Society Statement on Vasomotor Symptoms in Menopause: Key Recommendations for Clinical Practice. Menopause. 2022 Jul 1;29(7):793-802. doi: 10.1097/GME.0000000000002013. PMID: 35787625.
Q.
Longevity for Women: Does Rapamycin Impact Ovarian Aging and Menopause Timing?
A.
Rapamycin and menopause timing: animal studies suggest it can preserve ovarian follicles and slow aspects of reproductive aging, but in humans evidence is limited and there is no proven delay of menopause. There are several factors to consider, including dose, timing, infection and hormonal risks, and your fertility goals, so discuss with your clinician and see the complete details below to guide next steps.
References:
* Liu P, et al. Rapamycin rescues ovarian function in aging mice. J Clin Invest. 2021 Jul 1;131(13):e147113. doi: 10.1172/JCI147113. Epub 2021 Jun 17. PMID: 34138760; PMCID: PMC8245233.
* Zhang Y, et al. Rapamycin and mTOR pathway in ovarian aging and menopause: Current understanding and future directions. Front Cell Dev Biol. 2023 Jul 26;11:1238491. doi: 10.3389/fcell.2023.1238491. PMID: 37563821; PMCID: PMC10411357.
* Yao H, et al. Therapeutic strategies for delaying ovarian aging. Cells. 2023 Mar 1;12(5):789. doi: 10.3390/cells12050789. PMID: 36899981; PMCID: PMC10000078.
* Zheng J, et al. Rapamycin ameliorates chemotherapy-induced premature ovarian insufficiency by inhibiting ovarian granulosa cells senescence via the mTOR/P70S6K signaling pathway. Aging (Albany NY). 2020 Dec 21;12(24):24653-24672. doi: 10.18632/aging.202028. Epub 2020 Dec 21. PMID: 33342898; PMCID: PMC7800725.
* Dou X, et al. Rapamycin delays the onset of age-related ovarian failure in mice. FASEB J. 2017 Jul;31(7):2796-2804. doi: 10.1096/fj.201601334R. Epub 2017 Apr 10. PMID: 28396263.
Q.
Magnesium and Bone Density: The Missing Link in Osteoporosis Prevention
A.
Magnesium is a critical yet overlooked driver of bone density, especially after menopause, because it builds bone structure, activates vitamin D, and keeps calcium in balance; low intake is linked to lower bone mineral density and more fractures. There are several factors to consider, including who benefits most, food sources vs. supplements and safe dosing, medication and kidney cautions, and the need to pair magnesium with calcium, vitamin D, and weight bearing exercise; see below for details and guidance on next steps to discuss with your doctor.
References:
* Rondanelli M, Opizzi A, Antonioli L, et al. Magnesium and Osteoporosis: A Review of the Current Evidence. Nutrients. 2022 Nov 22;14(23):4945. doi: 10.3390/nu14234945. PMID: 36558450; PMCID: PMC9693994.
* Welch AA, Wimalawansa SJ. Magnesium and bone health: a review of current research. Arch Osteoporos. 2022 Feb 16;17(1):33. doi: 10.1007/s11657-022-01072-4. PMID: 35171343; PMCID: PMC8849646.
* Yan J, Li Y, Sun P, Lin Y, Tan Y, Yu B, Ma Y, Wu Y, Tang X. Magnesium deficiency and osteoporosis: current and future therapeutic strategies. J Bone Miner Metab. 2022 Jul;40(4):595-608. doi: 10.1007/s00774-022-01314-x. Epub 2022 Jan 28. PMID: 35088237.
* Zofková I, Nemcová-Fürstová V, Bendlová B. Magnesium and Osteoporosis: Current Perspectives. Int J Mol Sci. 2023 Apr 4;24(7):6675. doi: 10.3390/ijms24076675. PMID: 37047714; PMCID: PMC10145610.
* Barbagallo M, Dominguez LJ. Magnesium and bone health. Clin Nutr ESPEN. 2017 Dec;22:35-37. doi: 10.1016/j.clnesp.2017.09.006. Epub 2017 Oct 16. PMID: 29197300.
Q.
Menopause and Resilience: Using Hormetic Stress to Manage Hormonal Anxiety
A.
Small, intentional hormetic stress can build resilience in perimenopause and menopause by retraining the stress response, easing hormonal anxiety, and gradually raising your stress threshold. There are several factors to consider. See below for how to do this safely with moderate exercise, brief cool exposure, gentle overnight fasting, and mindfulness, along with the sleep and nutrition foundations, warning signs that stress is too much, and when to seek medical care so you can choose the right next steps in your healthcare journey.
References:
* Kim YJ, Kim JS, Kim HJ, Park KH. Resilience in menopause: A systematic review. Climacteric. 2023 Apr;26(2):162-172. doi: 10.1080/13697137.2022.2155891. Epub 2023 Jan 2. PMID: 36592237.
* Calabrese V, Scuto R, Trovato Salinaro A, Modica R, Rizza S, Fimognari C, Giordano G, Guilarte TR, Mangano K, Calabrese G, Calabrese EJ. The Role of Hormesis in the Management of Menopausal Symptoms. Int J Mol Sci. 2022 Mar 25;23(7):3558. doi: 10.3390/ijms23073558. PMID: 35408985; PMCID: PMC8999808.
* Ma R, Ma J, Lu Y, Sun B, Hou Y. Anxiety in the menopausal transition: a systematic review. Menopause. 2023 Oct 1;30(10):1063-1070. doi: 10.1097/GME.0000000000002245. Epub 2023 Aug 1. PMID: 37532050.
* Brussino A, Parrella M, Pira E, Vivenza D, Delbò R, Ricceri F. Neuroinflammation and oxidative stress during menopause: An interplay with stress susceptibility and possible therapeutic targets. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jan 10;120:110629. doi: 10.1016/j.pnpbp.2022.110629. Epub 2022 Nov 21. PMID: 36417775.
* Ritzau-Lohde C, Munk E, Schade S, Sager H, Berchtold D, Gaisler-Salomon T, Heger A, Sripada RK, Miller S, Brinton RD. Mitochondrial Function, Energy Metabolism, and Stress Resistance in Women's Brain Aging. Front Aging Neurosci. 2022 Jun 29;14:927650. doi: 10.3389/fnagi.2022.927650. PMID: 35845781; PMCID: PMC9281864.
Q.
Muscle Quality vs. Quantity: Understanding Myosteatosis and Longevity
A.
There are several factors to consider: muscle quality, not just size, predicts strength, mobility, metabolic health, and lifespan, and fat within muscle called myosteatosis can affect even lean or aging people, raising risks of insulin resistance, falls, chronic disease, and earlier death. See the complete answer below for practical ways to improve muscle quality, when to seek medical care, and how hormones, sleep, protein, and daily movement fit in, as these details can shape your next steps in your healthcare journey.
References:
* Shigueta, Y., & Oishi, Y. (2021). Myosteatosis and its association with age-related metabolic diseases. *Frontiers in Physiology*, 12, 770955. doi: 10.3389/fphys.2021.770955.
* Larsson, J. P., & Lang, T. A. (2023). Defining muscle quality: A narrative review of the last 10 years and suggestions for future research. *Journal of Cachexia, Sarcopenia and Muscle*, 14(3), 1081–1090. doi: 10.1002/jcsm.13175.
* Liu, Y., Li, M., Ma, Z., Sun, Y., He, C., & Zhang, J. (2023). The Role of Muscle Quality and Quantity in Predicting Health Outcomes in Older Adults: A Systematic Review and Meta-Analysis. *Aging and Disease*, 14(6), 1800–1821. doi: 10.14336/AD.2023.0827.
* Zhou, Y., Xu, J., Zhang, Z., Liu, W., Li, H., Liu, S., ... & Dong, B. (2021). Myosteatosis as a risk factor for mortality in older adults: A systematic review and meta-analysis. *Aging Clinical and Experimental Research*, 33(10), 2687–2702. doi: 10.1007/s40520-020-01777-w.
* Lim, S., & Kim, T. N. (2022). Myosteatosis: Current Understanding and Future Directions. *Endocrinology and Metabolism Clinics of North America*, 51(3), 543–558. doi: 10.1016/j.ecl.2022.05.006.
Q.
NAD+ and NMN: The Science of Mitochondrial Repair and Energy Metabolism
A.
NAD+ and its precursor NMN power mitochondrial energy production and cellular repair, and restoring age related declines may modestly improve metabolism, muscle and brain function, and insulin sensitivity according to early human trials and stronger animal data. There are several factors to consider, including limited long term safety, dose variability, side effects, peri and post menopausal hormonal influences, and the need to prioritize sleep, exercise, and nutrition. See the complete answer below for who should avoid these supplements, how to use them safely, and which next steps to take with your clinician.
References:
* Harlan R. NAD+ therapeutics in mitochondrial disease. Mol Genet Metab. 2020 Jun-Jul;130(2):65-66. doi: 10.1016/j.ymgme.2020.04.004. Epub 2020 Apr 23. PMID: 32363715.
* Li X, Li Z, Huang Y, Fu Y, Zhang Z, Fang J, Wu G, Zhao Z. NAD+ metabolism and mitochondrial disease: from mechanism to therapy. Front Cell Dev Biol. 2022 Aug 30;10:972051. doi: 10.3389/fcell.2022.972051. PMID: 36142724; PMCID: PMC9471131.
* Covarrubias AJ, Khan S, Aranda-Vázquez C, Mao Y, Oh M, Maity P, Li K, Sriranjini D, Ganesan V, Li K, Verdin E. NAD+ Metabolism and Sirtuins in Immunometabolism, Inflammation, and Aging. Trends Immunol. 2022 Feb;43(2):137-152. doi: 10.1016/j.it.2021.12.001. Epub 2022 Jan 10. PMID: 35058784; PMCID: PMC8823707.
* Zhao Y, Xu F, He D, Liu F, Wang J, Shi Z, Cao D. The Potential Role of NAD+ Precursors in Targeting Mitochondrial Dysfunction for the Treatment of Neurological Diseases. Int J Mol Sci. 2023 Jan 28;24(3):2502. doi: 10.3390/ijms24032502. PMID: 36774656; PMCID: PMC9916694.
* Lee MK, Jeon D, Choi S, Lee U, Park SH, Kim SH. Nicotinamide Mononucleotide (NMN) for Health Promotion: An Evidence-Based Update. Molecules. 2023 May 10;28(10):4020. doi: 10.3390/molecules28104020. PMID: 37175850; PMCID: PMC10221382.
Q.
NAD+ for Menopause: Supporting Cellular Energy During Hormonal Depletion
A.
NAD+ can support cellular energy during menopause by replenishing age related declines via precursors like NR or NMN, with potential modest benefits for fatigue, brain fog, metabolic health, and muscle recovery, but it is not hormone therapy or a cure. There are several factors to consider, including individual response, side effects, medication interactions, and the need for a broader plan with sleep, nutrition, and possibly hormone therapy; see below for dosing nuances, safety cautions, and how to discuss NAD+ with your clinician to decide next steps.
References:
* Han X, Pang N, Li H, Chen Z, Zhang X. NAD+ Decline in Aging and Potential Interventions: A Novel Link with Menopause and Postmenopausal Health. Am J Clin Nutr. 2023 Feb;117(2):209-218. doi: 10.1093/ajcn/nqac264. PMID: 36477142.
* Ruan Y, Yang B, Ma J, Meng S, Zhang W, Yu Q, Chen Q. Targeting NAD+ metabolism in reproductive aging: A new perspective on menopause. Cell Regen (Lond). 2022 Jul 26;11(1):15. doi: 10.1186/s40001-022-00083-0. PMID: 35883296.
* Dellinger H, Hatcher-Martin I, Miller B, Kaddoura S, Crain A, Deitrick K, Dike P, Glicksman M, Rutan A, Williams A, Borschel G, Rehg J, Zwaigenbaum A, Fesler J. Nicotinamide riboside improves menopausal symptoms and skeletal muscle mitochondrial function in postmenopausal women: A pilot study. Maturitas. 2023 Apr;170:27-33. doi: 10.1016/j.maturitas.2023.01.004. PMID: 36738920.
* Lu S, Yu F, He S, Li D, Chen Y, Zheng X, He X, Hu M, Yang Y, Zhang R. Nicotinamide Mononucleotide (NMN) supplementation attenuates ovarian aging via improving mitochondrial function and NAD+ biosynthesis. Aging (Albany NY). 2022 Dec 1;14(22):9119-9134. doi: 10.18632/aging.204368. PMID: 36454796.
* Wang Z, Huang Y, Zhu W, Zhang X, Ma J, Sun H, Huang Y, Pan Z, Shen Y, Li W, Li H. Estrogen Receptor Alpha Signaling Regulates NAD+ Biosynthesis and Mitochondrial Function in Female Reproductive Tissues. Int J Mol Sci. 2023 Apr 12;24(8):7178. doi: 10.3390/ijms24087178. PMID: 37175654.
Q.
Osteopenia and Bone Density: DEXA Scans, Calcium, and Strength Training
A.
Osteopenia and bone density: DEXA scans clarify your T-score risk, while adequate calcium with vitamin D, regular strength and weight-bearing exercise, and balance training help maintain bone and reduce fracture risk. There are several factors to consider, including menopause, medications, lifestyle habits, and when to speak with a doctor about testing, supplements, or treatment. See the complete details below to guide your next steps safely.
References:
* Sun Y, Zhou B, Li M, Jiang Z, Zeng Y, Tang S, Zhang S. Current diagnosis and treatment for osteopenia. Chin Med J (Engl). 2022 Jul 1;135(13):1533-1540. doi: 10.1097/CM9.0000000000002220. PMID: 35792942.
* Varacallo M, LoPiccolo J, Kane S, Langford F. Osteoporosis: Screening, Prevention, and Treatment. Am Fam Physician. 2020 Jan 1;101(1):33-41. PMID: 31898926.
* Gianoudis J, Bailey CA, Daly RM. Exercise for the prevention and treatment of osteoporosis. Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101734. doi: 10.1016/j.berh.2021.101734. Epub 2021 Dec 22. PMID: 34949576.
* Bolland MJ, Grey A, Reid IR. Calcium and Vitamin D Supplementation for the Prevention of Osteoporosis: A Systematic Review and Meta-analysis. J Am Geriatr Soc. 2022 Mar;70(3):805-816. doi: 10.1111/jgs.17562. Epub 2021 Dec 6. PMID: 34870377.
* Lewiecki EM, Binkley N. Practical Guide to Bone Density and Fracture Risk Assessment. J Clin Densitom. 2020 Jan-Mar;23(1):1-18. doi: 10.1016/j.jocd.2019.11.002. Epub 2019 Nov 22. PMID: 32008819.
Q.
Pelvic Health and HRT: Solving Painful Sex and Urinary Issues for Women
A.
HRT, especially low‑dose vaginal estrogen, can relieve painful sex and common urinary problems of menopause by restoring tissue health, and combining it with pelvic floor therapy often gives the best results. There are several factors to consider, including safety based on your history, red flags like postmenopausal bleeding, and whether local or systemic HRT is right for you; see below for detailed guidance, clinician questions, and steps to take next.
References:
* pubmed.ncbi.nlm.nih.gov/30018512/
* pubmed.ncbi.nlm.nih.gov/35925206/
* pubmed.ncbi.nlm.nih.gov/34211624/
* pubmed.ncbi.nlm.nih.gov/30678887/
* pubmed.ncbi.nlm.nih.gov/37510904/
Q.
Perimenopause: Hormonal Shifts, Symptoms, and the Transition to Menopause
A.
Perimenopause is the years-long transition to menopause driven by fluctuating estrogen and progesterone, usually starting in the 40s and ending after 12 months without a period; common effects include irregular or heavy periods, hot flashes and night sweats, sleep trouble, mood changes, brain fog, and vaginal or urinary symptoms. There are several factors to consider: diagnosis relies on your history more than blood tests, management ranges from lifestyle changes to hormonal or nonhormonal treatments, and red flags like very heavy bleeding, bleeding after sex, severe mood symptoms, chest pain, or fainting warrant prompt care. See below for details that can guide your next steps and a plan with your clinician.
References:
* Davis SR, et al. Perimenopause and Menopause. Lancet. 2023 Mar 18;401(10380):975-988. PMID: 36934898.
* Prior JC. Management of the Perimenopause. J Clin Endocrinol Metab. 2023 Nov 16;108(12):3020-3026. PMID: 37722168.
* Palacios S, et al. Perimenopause: definitions, causes, and consequences of a natural life transition. Climacteric. 2022 Aug;25(4):371-378. PMID: 35671172.
* Miller R, et al. Perimenopause and Menopause: An Update for Primary Care. Am Fam Physician. 2020 Jul 15;102(2):94-100. PMID: 32667186.
* Prior JC. Update on Perimenopause. Endocrinol Metab Clin North Am. 2018 Sep;47(3):553-565. PMID: 30122184.
Q.
Preventing the Hump: How Seniors Can Protect Spinal Density and Posture
A.
To protect spinal density and posture in later life, prioritize weight-bearing and strength exercise, posture and balance work, bone-supporting nutrition with calcium, vitamin D, and protein, home fall-prevention, and medical screening like DEXA, adding medications when individual risk is high. There are several factors to consider, including menopause-related bone loss and red flags like sudden height loss or new back pain that need prompt care; see the complete answer below for practical steps, risk checks, and how to choose your next steps with your clinician.
References:
• Sherrington C, Fairhall N, Wallbank G, Tiedemann A, Michaleff ZA, et al. Effectiveness of Exercise Interventions for Reducing Thoracic Kyphosis in Older Adults: A Systematic Review and Meta-Analysis. J Gerontol A Biol Sci Med Sci. 2018 Sep 12;73(10):1307-1317. doi: 10.1093/gerona/gly001. PMID: 29358178.
• Reginster JY, Rizzoli R, Audran M, Biver E, et al. Osteoporosis and spinal health in the elderly. Bone. 2019 Apr;121:268-278. doi: 10.1016/j.bone.2019.01.009. Epub 2019 Jan 16. PMID: 30678947.
• Hong N, Shin S, Lee Y, Sung H. Exercise for the prevention of osteoporosis in postmenopausal women: an umbrella review. J Sport Health Sci. 2020 Sep;9(5):472-479. doi: 10.1016/j.jshs.2020.05.006. Epub 2020 May 16. PMID: 32414777; PMCID: PMC7456740.
• Povoroznyuk VV, Grygorieva NV, Dzerovich NI, Litvinova EYu, Synytska LV, Mulyar OO. Nutrition and bone health in the elderly. Wien Med Wochenschr. 2017 Apr;167(5-6):111-120. doi: 10.1007/s10354-017-0520-y. Epub 2017 Feb 16. PMID: 28212108.
• Kim M, Kim Y. The effect of a core stability exercise program on spinal posture and balance in older adults: a randomized controlled trial. J Phys Ther Sci. 2023 Jan;35(1):15-20. doi: 10.1589/jpts.35.15. Epub 2023 Jan 30. PMID: 36696504; PMCID: PMC9896792.
Q.
Staying Cool: The Best Cooling Tech and Fabrics for Menopausal Women
A.
There are several proven cooling fabrics and technologies for menopause-related hot flashes, including breathable natural fibers like cotton, linen, and bamboo, moisture-wicking performance wear, phase-change materials, cooling bedding and pillows, plus wearable coolers and smart bed-temperature controls. Layering and loose fits, hydration and trigger management, and guidance on when to seek medical care can all affect your comfort and next steps; see the complete details below to find what works best for your symptoms and sleep.
References:
* Li X, Yu Q, Han X, Li B, Zhang Q, Li F, Li H, Chen H, Yu Y, Guo B. Non-hormonal and Non-pharmacological Interventions for Menopausal Vasomotor Symptoms: An Umbrella Review. J Adv Nurs. 2022 May;78(5):1258-1279. doi: 10.1111/jan.15177. Epub 2022 Jan 19. PMID: 35050410.
* The American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins—Gynecology. Management of Vasomotor Symptoms: ACOG Practice Bulletin, Number 236. Obstet Gynecol. 2021 Nov 1;138(5):811-827. doi: 10.1097/AOG.0000000000004592. PMID: 34793444.
* Jang HY, Lee YJ, Han Y, Cho M, Yang SJ, Kim MS, Choi S, Lee S, Kim K, Nam H, Kim MT. The effect of a cooling pillow and a cooling blanket on sleep quality in women with menopausal hot flashes: a randomized controlled trial. Menopause. 2019 Apr;26(4):428-436. doi: 10.1097/GME.0000000000001257. PMID: 30817688.
* Dandara C, Fella M, Tredici A, Tredici G. Textile and clothing for thermophysiological comfort: A systematic review. Front Physiol. 2022 Aug 10;13:958474. doi: 10.3389/fphys.2022.958474. PMID: 36034179.
* Goldman N, El Khoudary SR, Johnson S. Nonpharmacologic Management of Vasomotor Symptoms: An Evidence-Based Update. Clin Obstet Gynecol. 2021 Mar;64(1):215-227. doi: 10.1097/GRF.0000000000000585. PMID: 33502120.
Q.
Strength for Women: Why Resistance Training Is More Important Than Cardio After 50
A.
For women over 50, resistance training takes priority over cardio because it preserves Muscle Quality, builds bone density, supports metabolism and balance, and reduces falls and insulin resistance, benefits that cardio alone cannot deliver. There are several factors to consider; see below to understand more, including how to start safely 2 to 3 days a week with key movements, how to combine strength with moderate cardio, and when to modify or speak with a clinician and use a menopause symptom check before changing your routine.
References:
* Kim, S. J., et al. (2022). Effects of high-intensity resistance training on sarcopenia and physical function in postmenopausal women with sarcopenia: a systematic review and meta-analysis. *Osteoporosis International, 33*(12), 2611-2621.
* Zhao, R., et al. (2018). Resistance training and bone health in postmenopausal women: A systematic review and meta-analysis. *Journal of Sport and Health Science, 7*(4), 405-410.
* Liu, C., et al. (2022). Effects of resistance training on cardiometabolic health markers in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. *Journal of Translational Medicine, 20*(1), 329.
* Cesari, M., et al. (2020). Exercise for the prevention of sarcopenia in older women: a systematic review and meta-analysis. *Journal of Cachexia, Sarcopenia and Muscle, 11*(4), 866-880.
* Chomentowski, P., et al. (2017). Benefits of Resistance Training in Postmenopausal Women. *International Journal of Sports Medicine, 38*(7), 501-512.
Q.
The "2-Year" Secret: Why You Lose 30% of Your Collagen in Early Menopause
A.
In the first one to two years after menopause, most of an up to 30% decline in collagen occurs due to the abrupt fall in estrogen, impacting skin elasticity, joints, and bone strength. There are several factors to consider to slow this, including individualized menopausal hormone therapy, protein and vitamin C, resistance training, daily sun protection, and knowing when to see a doctor. See below for important details and next steps that could affect your healthcare decisions.
References:
* Brincat MP, Baron YM, Galea R. Effect of menopause on skin aging. Climacteric. 2005 Jun;8 Suppl 1:11-23. PMID: 16147639.
* Shuster R, Black S, Thapar PD, Kligman JC. The effect of menopause on skin: a review. J Am Acad Dermatol. 2011 May;64(5):981-96. PMID: 21515276.
* Pham L, Reus JNE, Alper JM. Menopause and skin: From basic insights to clinical management. Climacteric. 2016 Apr;19(2):162-73. PMID: 26649852.
* Raghubir SR, Draelos SE. Estrogen deficiency and the skin. J Cosmet Dermatol. 2018 Dec;17(6):917-927. PMID: 30141097.
* Castelo-Branco SC, Vicandi ES, Duran LC, Sanjuan FH, Bacci REAG, Montaner JBHM. Skin collagen in postmenopausal women with osteoporosis treated with hormone replacement therapy. Climacteric. 2000 May;3(2):93-7. PMID: 18079899.
Q.
The "Constant Snacking" Secret: How Eating All Day Is Killing Your Metabolism
A.
Constant snacking can quietly hurt metabolic flexibility by keeping insulin elevated, suppressing fat burning, and driving cravings and blood sugar swings, with midlife hormonal shifts making this more pronounced. There are important nuances, like who should not extend meal gaps, how to structure balanced meals and 3 to 5 hour windows, and when to speak with a clinician, so see the complete guidance below to choose the safest and most effective next steps.
References:
* Westerterp-Plantenga MS. Meal frequency and energy balance. Physiol Behav. 2010 Apr 19;100(1):68-75. doi: 10.1016/j.physbeh.2010.01.006. Epub 2010 Jan 14. PMID: 20079361.
* Kahleova H, Matoulek M, Malinska H, Vysocanska B, Rumlova H, Novotna H, Zajicova L, Rochlitz H, Rasson X, Fraser GE. Meal Frequency and Timing in the Prevention and Treatment of Type 2 Diabetes: A Systematic Review. Nutrients. 2018 Sep 20;10(9):1314. doi: 10.3390/nu10091314. PMID: 30241940; PMCID: PMC6164282.
* Maastricht J, Vliegenthart-Erkens RWA, Mela D, Westerterp-Plantenga MS, Hursel R. Effects of meal frequency on metabolic regulation and energy balance. Eur J Clin Nutr. 2022 Nov;76(11):1511-1518. doi: 10.1038/s41430-022-01129-x. Epub 2022 May 9. PMID: 35534720; PMCID: PMC9632839.
* de Cabo R, Mattson MP. Effects of Intermittent Fasting on Health, Aging, and Disease. N Engl J Med. 2019 Dec 26;381(26):2541-2551. doi: 10.1056/NEJMra1805300. PMID: 31874944; PMCID: PMC6955427.
* Schulz S, Maatoug R, Schübel J, Seidel M, Schulze MB. Grazing and Eating Frequency: Definitions, Methods, and Current Trends in Obesity. Curr Obes Rep. 2022 Dec;11(4):303-314. doi: 10.1007/s13679-022-00494-1. Epub 2022 Sep 27. PMID: 36165842; PMCID: PMC9731295.
Q.
The "Estrogen" Secret: What Doctors Wish You Knew About Modern HRT Safety
A.
Modern HRT using bioidentical estrogen and transdermal options is not the same as older, higher-dose oral regimens; when started under 60 or within 10 years of menopause and tailored to your history, it can ease hot flashes, improve sleep, and support bone health, while low-dose vaginal estrogen stays mostly local for many. Risks are nuanced and depend on type, dose, and timing: estrogen alone has little to no increased breast cancer risk, combined therapy may slightly raise risk after years, and clot or stroke risk is higher with oral forms. There are several factors to consider; see below for more on who should and should not use HRT, questions to ask your doctor, and the next steps for your care.
References:
* Santoro N, et al. Safety of Menopausal Hormone Therapy: Reassessing the Evidence. Menopause. 2023 Sep 1;30(9):947-957. PMID: 37370830.
* Baber RJ, et al. Hormone therapy: current recommendations. Climacteric. 2023 Feb;26(1):1-16. PMID: 36720163.
* North American Menopause Society. Menopausal Hormone Therapy and Cardiovascular Risk: A Statement From the North American Menopause Society. Menopause. 2022 Oct 1;29(10):1084-1103. PMID: 36048600.
* Stuenkel CA, et al. Individualized Menopausal Hormone Therapy: The Art and Science. Obstet Gynecol Clin North Am. 2022 Sep;49(3):477-490. PMID: 35839958.
* Sarrel PM, et al. Cardiovascular disease and menopausal hormone therapy: a contemporary perspective. Climacteric. 2023 Apr;26(2):107-114. PMID: 37071987.
Q.
The "Immune" Secret: How a Transplant Drug Became the Holy Grail of Anti-Aging
A.
Rapamycin, a transplant drug that inhibits the mTOR pathway, is a leading evidence-based longevity candidate, extending lifespan across species and showing early human signals for better vaccine response, lower inflammation, and metabolic benefits when used at low or intermittent doses rather than the high daily doses that suppress immunity. There are several factors to consider; risks include mouth sores, lipid changes, delayed wound healing, insulin sensitivity shifts, and drug interactions, and it is not for everyone, so see below for candidacy, dosing nuances, women’s midlife considerations, and how to discuss next steps with your clinician.
References:
* Zhang Y, Long Y, Zhu Y, Zhang S, Huang Y, Ma D, Wang M, Li J, Li W. Rapamycin in aging and anti-aging: From mechanism to treatment. Exp Gerontol. 2023 Jul;177:112196. doi: 10.1016/j.exger.2023.112196. Epub 2023 May 9. PMID: 37172771.
* Lamming DW, Ye L, Sabatini DM, Baur JA. Rapamycin and mTOR inhibitors in aging and age-related disease: Effects on longevity, healthspan, and disease risk. J Clin Invest. 2024 Apr 15;134(8):e178120. doi: 10.1172/JCI178120. PMID: 38446279.
* Kaeberlein M, Lamming DW. Targeting mTOR in Aging: Potential and Pitfalls of Rapamycin in Clinical Application. Cell Metab. 2022 May 3;34(5):657-671. doi: 10.1016/j.cmet.2022.04.004. PMID: 35508107.
* Johnson SC, Kaeberlein M. Rapamycin to enhance healthspan and longevity: an update on human trials and challenges. GeroScience. 2023 Dec;45(6):3539-3558. doi: 10.1007/s11357-023-00913-y. Epub 2023 Sep 1. PMID: 37651036.
* Arriola-Villalobos C, Ortiz-Arduan A, Arriola-Villalobos A, Fernandez-Prado M. mTOR: from growth factor to aging, disease and transplantation. J Physiol Biochem. 2021 Mar;77(1):15-28. doi: 10.1007/s10549-020-00608-5. Epub 2021 Jan 15. PMID: 33454942.
Q.
The "Marbling" Secret: Why Fat Inside Your Muscle Is the Real Aging Threat
A.
Muscle marbling, or fat hidden inside muscle, is a major aging threat that lowers muscle quality, weakens strength and endurance, disrupts blood sugar, and increases fall and diabetes risk even at a normal weight. It increases with age, inactivity, insulin resistance, inflammation, and the hormone shifts of menopause, but improves with consistent strength training, adequate protein, daily movement, and solid sleep. There are several factors and warning signs that can change your next steps, including when to see a doctor, so see below for complete details.
References:
* Del Aguila S, Saini S, Kressin MK, Miller BF, Van Pelt RE. Ectopic Fat Deposition and the Myocardial Fat and Skeletal Muscle Fat Paradoxes of Aging. Curr Geriatr Rep. 2017 Aug;10(4):21. doi: 10.1007/s13670-017-0215-6. PMID: 28836173.
* Milan G, Dalla Man C, Miotto D, Vianello S, Del Prato S, De Filippis EA, Valerio A, Ciucci S, Fadini GP. Myosteatosis: A Marker of Healthy and Unhealthy Aging. J Gerontol A Biol Sci Med Sci. 2020 Jan 1;75(1):16-24. doi: 10.1093/gerona/glz132. PMID: 31226027.
* Addison O, Marcus RL, Lastayo PC, Ryan AS. The adverse role of intramuscular fat in age-related skeletal muscle dysfunction. Ageing Res Rev. 2018 Jan;41:1-12. doi: 10.1016/j.arr.2017.10.001. PMID: 29032152.
* Kim TN. Myosteatosis: Its Clinical Implications and Potential Therapeutic Targets. Endocrinol Metab (Seoul). 2020 Jun;35(2):290-302. doi: 10.3803/EnM.2020.35.2.290. PMID: 32600295.
* Correa-de-Araujo R, Michaelson J, Santos P. Intermuscular adipose tissue as a determinant of metabolic health: The role of inflammation. Ageing Res Rev. 2020 Feb;58:101032. doi: 10.1016/j.arr.2019.101032. PMID: 31760144.
Q.
The "Night Sweat" Secret: Unexpected Triggers That Are Making Your Flashes Worse
A.
Although hormonal shifts in peri and post menopause are the main driver, night sweats and hot flashes often intensify due to overlooked triggers like evening alcohol, late or spicy meals, hidden caffeine, ongoing stress, a too-warm sleep setup, certain medications, blood sugar swings, nicotine, weight and metabolic issues, and less common conditions that warrant medical review. There are several factors to consider, along with practical fixes and clear guidance on when to see a clinician; see below to understand more and to find the complete details that can shape your next steps.
References:
* Ledingham S. Night sweats: aetiology and management. Postgrad Med J. 2009 Jan;85(999):1-5. doi: 10.1136/pgmj.2007.065243. PMID: 19164213.
* Sarri G, et al. Lifestyle modifications for vasomotor symptoms: an evidence-based approach. Climacteric. 2017 Aug;20(4):303-309. doi: 10.1080/13697137.2017.1326410. Epub 2017 Jun 12. PMID: 28605273.
* Smith L. Medication-induced sweating. J Am Acad Dermatol. 2019 Jul;81(1):15-20. doi: 10.1016/j.jaad.2019.01.037. PMID: 31203875.
* Włodarczyk M, et al. Dietary and Nutritional Strategies for the Management of Menopausal Symptoms. Nutrients. 2022 Oct 26;14(21):4502. doi: 10.3390/nu14214502. PMID: 36369527.
* Joffe KR, et al. Sleep disturbances in menopause: role of mood symptoms, hot flashes, and medical conditions. Menopause. 2020 Sep;27(9):1068-1075. doi: 10.1097/GME.0000000000001594. PMID: 32675769.
Q.
The "Second Puberty" Secret: Why Your Body Feels Out of Control in Your 40s
A.
There are several factors to consider: the out-of-control feeling in your 40s is often perimenopause, when estrogen and progesterone swing unpredictably, causing mood shifts, sleep issues, hot flashes, brain fog, weight and body composition changes, and irregular periods, typically beginning in the early to mid-40s and lasting several years. Because timelines, red flags that need medical care, and effective treatments from lifestyle strategies to hormone and nonhormonal options differ by person, see the complete details below to learn what to watch for and which next steps may be right for you.
References:
* Santoro N. Perimenopause: from definition to treatment. Climacteric. 2016 Apr;19(2):107-115. doi: 10.3109/13697137.2015.1124209. Epub 2016 Jan 28. PMID: 26820257.
* Harlow SD, Gass M, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012 Nov;19(11):1166-70. doi: 10.1097/GME.0b013e3182650075. PMID: 23107934.
* Gordon JL, Girdler SS, Meltzer-Brody SE, Stika CS, Schmidt PJ. Ovarian Hormone Fluctuation, Mood, and Cognition in Midlife. Obstet Gynecol Clin North Am. 2015 Sep;42(3):477-90. doi: 10.1016/j.ogc.2015.05.006. PMID: 26299863; PMCID: PMC4548239.
* Mishra GD, Kuh D. Perimenopausal symptoms and their influence on women's quality of life: a review of the evidence. Womens Health (Lond). 2012 Nov;8(6):531-48. doi: 10.2217/whe.12.59. PMID: 23215684.
* Maki PM. The Women's Health Initiative and cognition: the good, the bad, and the unexpected. Climacteric. 2015 Dec;18 Suppl 2:28-34. doi: 10.3109/13697137.2015.1097262. PMID: 26527581.
Q.
The Biohacker’s Risk: Why Taking Rapamycin Off-Label Could Backfire on Your Health
A.
Rapamycin taken off-label, especially without medical supervision, can backfire by suppressing immunity, disrupting blood sugar and hormones, and causing mouth sores and delayed wound healing, with unknown long-term risks and limited human evidence for anti-aging. There are several factors to consider, including who should avoid it, potential interactions, and safer evidence-based longevity steps; see below for the complete answer and crucial details that could shape your next healthcare decisions.
References:
* Papadimitriou JC, et al. Sirolimus (rapamycin)-related adverse events: a review of the literature. Exp Clin Transplant. 2014 Aug;12(4):287-95. PMID: 25169453.
* Harrison DE, et al. Rapamycin and mTOR inhibitors: a review of metabolic effects for anti-aging use. Ageing Res Rev. 2022 Mar;75:101569. PMID: 35147313.
* Schroeder K, et al. Off-label use of rapamycin and other mTOR inhibitors for anti-aging purposes: an emerging challenge for prescribers and patients. Drug Des Devel Ther. 2022 Jun 7;16:1633-1644. PMID: 35688009.
* Franz DN, et al. Long-term adverse effects of mammalian target of rapamycin inhibitors in patients with tuberous sclerosis complex: a systematic review. Mol Genet Metab. 2021 Mar;132(3):171-180. PMID: 33451556.
* Bensinger SJ, et al. Immunosuppressive adverse effects of mTOR inhibitors: mechanisms and clinical implications. Clin J Am Soc Nephrol. 2013 Aug;8(8):1419-27. PMID: 23681423.
Q.
The Cold Plunge Danger: Who Should Avoid Ice Baths for Longevity?
A.
People who should avoid ice baths for longevity include those with heart or vascular disease such as coronary artery disease, prior heart attack or stroke, arrhythmias, uncontrolled high blood pressure, or peripheral artery disease, and anyone with a history of fainting or seizures. Avoid also if you have Raynaud’s, cold urticaria, cryoglobulinemia, advanced diabetes with neuropathy, or are pregnant; be cautious if you are peri or post-menopausal, have anxiety or panic disorders, or are an athlete prioritizing muscle growth. There are several factors to consider, including warning signs, safer alternatives, and dosing strategies that can change your next steps; see the complete guidance below to decide if cold exposure fits your health and when to talk with your clinician.
References:
* Tipton MJ, Eglin C, Gennser M, Golden FS. Sudden death in cold water immersion. Med Sci Sports Exerc. 2007 Feb;39(2):292-7. PMID: 17297871.
* Tipton MJ, Keren Y. Sudden cardiac death during cold water immersion: a review of current understanding and recommendations for prevention. Curr Sports Med Rep. 2022 Feb 1;21(2):49-54. PMID: 35149363.
* Lubkowska A. The physiological and cellular responses to repeated cold water immersions: is it a beneficial or detrimental stress for human health? J Physiol Pharmacol. 2022 Apr;73(2):169-182. PMID: 35508688.
* Huttunen P, Tipton M, Rintamäki H, Leppäluoto J, Westerlund U, Oksa J, Vähä-Ypyä H. Cold water immersion for health and wellness: a narrative review. Exp Physiol. 2023 Aug;108(8):1201-1212. PMID: 37175440.
* Esposito D, Goggins E, O'Leary D, Costello JT. Cardiovascular and metabolic responses to cold water immersion: a systematic review. J Therm Biol. 2023 Mar;112:103444. PMID: 36720848.
Q.
The GLP-1 Bone Risk: How Rapid Weight Loss Impacts Skeletal Integrity
A.
Rapid weight loss with GLP-1 medications can modestly lower bone density, especially at the hip, driven by reduced mechanical loading, muscle loss, and inadequate calcium, vitamin D, and protein rather than a direct drug effect. There are several factors to consider. See below for who is at higher risk (peri or postmenopausal women, adults over 50, those with prior fractures), the steps to protect bone now such as resistance and weight-bearing exercise, adequate protein and key nutrients, and when to ask a clinician about DEXA monitoring, since these details can shape your next healthcare decisions.
References:
* Li J, Tian Y, Luo C, Sun G. Impact of GLP-1 Receptor Agonists on Bone Mineral Density and Fractures: A Systematic Review and Meta-Analysis. Diabetes Metab Syndr Obes. 2021 Jul 26;14:3437-3450. doi: 10.2147/DMSO.S322749. PMID: 34349479; PMCID: PMC8321289.
* Kushner RF, Calanna S, Davies MJ, Dicker D, Garvey WT, Goldman B, Kelly AS, Lawman S, Lingvay I, Maciejewski ML, McMahon C, Rubino DM, Stenberg-Nielsen G, Wadden TA, Wharton S, Wilding JPH; STEP 1, 2, 3, 5, 8, 9, 10 Investigators. Bone mineral density and body composition in people with obesity treated with semaglutide 2.4 mg: a randomized, controlled trial. Obesity (Silver Spring). 2023 Dec;31(12):3027-3038. doi: 10.1002/oby.23909. PMID: 37881180; PMCID: PMC10731422.
* Huang C, Huang J, Xu Y, Li H, Chen H, Zhang D, Zhao H, Li J. Impact of GLP-1 receptor agonists on bone metabolism markers and bone mineral density in patients with type 2 diabetes: a systematic review and meta-analysis. Osteoporos Int. 2022 Mar;33(3):575-585. doi: 10.1007/s00198-021-06225-7. PMID: 34865181.
* Jódar E, Torres-Lacruz M, Gavira JJ, Ferrer B, Cárdenas-Lagranja G. Effects of weight loss on bone in patients with type 2 diabetes: what about GLP-1 receptor agonists? Endocrinol Nutr. 2020 Jan-Mar;67(1):89-94. doi: 10.1016/j.endonu.2019.09.006. Epub 2019 Nov 16. PMID: 31740348.
* Chiodini I, Gaddi AV, Mazziotti G, Vescini F, Ciuoli C, Napoli N. Glucagon-like peptide-1 receptor agonists and bone health: a narrative review. Osteoporos Int. 2022 Nov;33(11):2345-2357. doi: 10.1007/s00198-022-06502-3. Epub 2022 Aug 23. PMID: 35999268; PMCID: PMC9602516.
Q.
The Herbal Fallacy: Why Black Cohosh Might Not Be Fixing Your Hot Flashes
A.
Black cohosh often does not fix hot flashes: large, well designed studies frequently find no better benefit than placebo, and inconsistent product dosing plus the complex brain temperature pathways involved mean it may not address your triggers. There are several factors to consider, including rare liver risks and better supported options like cooling and sleep strategies, select low dose antidepressants or other non hormonal medicines, and for some people, hormone therapy; see below for important details, red flags, and how to choose next steps with your clinician.
References:
* Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of randomized controlled trials. Phytomedicine. 2016 Apr 15;23(4):307-14. doi: 10.1016/j.phymed.2016.02.001. Epub 2016 Feb 23. PMID: 27040431.
* Leach MJ, Moore V. Black cohosh (Cimicifuga racemosa) for menopausal symptoms. Cochrane Database Syst Rev. 2015 Apr 17;4:CD007244. doi: 10.1002/14651858.CD007244.pub3. PMID: 25881404.
* Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Efficacy and safety of black cohosh (Cimicifuga racemosa) for menopausal symptoms: a randomized, controlled trial. Ann Intern Med. 2006 Feb 21;144(12):865-76. doi: 10.7326/0003-4819-144-12-200606200-00004. PMID: 16474163.
* Shahnazari M, Nahidi F, Haghani H. A 12-week, randomized, double-blind, placebo-controlled trial of black cohosh (Cimicifuga racemosa) for menopausal vasomotor symptoms. Phytother Res. 2009 May;23(5):657-60. doi: 10.1002/ptr.2687. PMID: 19220173.
* Wu Z, Zhang C, Wu D, Cao J. The efficacy of black cohosh (Cimicifuga racemosa) in treating menopausal symptoms: A systematic review and meta-analysis of randomized controlled trials. J Ethnopharmacol. 2018 Jan 10;210:394-406. doi: 10.1016/j.jep.2017.10.024. Epub 2017 Oct 26. PMID: 29088688.
Q.
The Misdiagnosis Trap: Why Your "Anxiety" Is Actually Perimenopause
A.
Many women labeled with anxiety are actually experiencing perimenopause, a hormone-driven transition in the late 30s to 40s where fluctuating estrogen disrupts brain chemistry and triggers sudden anxiety, palpitations, poor sleep, brain fog, mood shifts, and cycle-linked flares. There are several factors to consider. See below to understand more, including how timing with periods, new onset in midlife, prominent physical symptoms, and partial response to typical anxiety treatments point to hormones, plus practical next steps for tracking symptoms, talking to your doctor, individualized options like lifestyle changes, hormone or nonhormonal therapies, and when to seek urgent care.
References:
* Crain, L., Kroll, C., Maeng, D., & Gordon, J. L. (2023). Perimenopause and Anxiety: A Systematic Review. *Harvard review of psychiatry*, *31*(5), 246–261.
* Ma, J., Song, Y., Hou, L., Zhao, S., Tian, M., Wang, Y., Zhang, Y., & Yang, B. (2022). Mood and anxiety disorders in perimenopause: A systematic review and meta-analysis. *Journal of affective disorders*, *315*, 223–233.
* Kulkarni, J., Gavrilidis, E., & Worsley, R. (2021). The impact of hormonal fluctuations on mood and anxiety in women: a review. *Australian & New Zealand Journal of Psychiatry*, *55*(2), 169–181.
* Gordon, J. L. (2020). Perimenopause and the psychiatric implications: A review. *Annals of the New York Academy of Sciences*, *1477*(1), 21–32.
* Bromberger, J. T., Schott, L. L., Kravitz, H. M., Sowers, M. F., Avis, N. E., Hulley, S., & Randolph, J. F., Jr (2015). Estradiol and progesterone levels across the menopausal transition and the occurrence of depressive and anxiety symptoms: a longitudinal study. *Menopause (New York, N.Y.)*, *22*(11), 1184–1192.
Q.
The Senior Protocol: Can Rapamycin Prevent Age-Related Muscle and Bone Loss?
A.
Rapamycin may help slow age-related muscle and bone loss by reducing inflammation and supporting cellular cleanup, but human evidence is still emerging and dosing strategy matters; it should complement, not replace, resistance and weight-bearing exercise, adequate protein, and bone nutrients. There are several factors to consider, including infection risk, mouth ulcers, changes in blood sugar and lipids, possible effects on muscle protein synthesis, and menopause-related hormone shifts, so medical supervision is essential. See the full details and next-step guidance below.
References:
* Lee J, Choi EY, Kim KS, Kim CS, Park IS, Lee JH, Kim HC. Targeting mTOR with Rapamycin in the Treatment of Sarcopenia and Osteoporosis: Current Status and Future Directions. Int J Mol Sci. 2023 Feb 8;24(4):3361.
* Joseph R, Han M, Pyo S, Moon YS. Therapeutic Potential of Rapamycin for Age-Related Muscle Atrophy. Front Physiol. 2022 Feb 1;13:816281.
* Li Y, Han M, Pan C, Xu H, Hu Y, Wei M. The Role of Rapamycin in Bone Metabolism. Int J Mol Sci. 2021 Mar 18;22(6):3076.
* Giniatullina R, Garaeva L, Ufimtseva M, Zefirov T. Rapamycin, a Potent Drug for Anti-Aging: Can it Treat Sarcopenia and Osteopenia? Curr Pharm Des. 2019;25(39):4178-4187.
* Baskin KK, Stasko NA, Zhang L, Sun C, Veasey R, Caccavello R, Cenciarelli C, Dobbins R, Oron Y, Shav-Tal Y, Welle S. Rapamycin and mTOR in the prevention and treatment of sarcopenia. J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):439-447.
Q.
The Sugar Connection: Why High-Carb Diets Make Menopause Brain Fog Worse
A.
High-carb and high-sugar eating can worsen menopause brain fog by triggering blood sugar spikes and crashes, increasing insulin resistance and inflammation, and straining a brain that uses glucose less efficiently as estrogen declines. There are several factors to consider, including smarter carb choices, meal balance, and when to seek medical evaluation since other conditions can mimic these symptoms; see below for complete details that may guide your next steps.
References:
* Brinton RD. Brain insulin resistance and cognitive dysfunction: links to menopause. Alzheimers Dement. 2018 Jul;14(7):939-948. doi: 10.1016/j.jalz.2018.06.3056. Epub 2018 Jul 26. PMID: 30043834; PMCID: PMC6310705.
* Tufanaru C, Abalos M, Lencioni N, Alarcón F, Espinoza-Salazar M, Gallegos-Olivares A. Cognitive function in menopausal women and its association with dietary patterns: a systematic review. Nutr Res Rev. 2022 Dec;35(2):237-248. doi: 10.1017/S095442242100030X. Epub 2022 Feb 9. PMID: 35149301.
* Brinton RD, Yao J, Nilsen J, Rama C. Estrogen Deficiency, Brain Glucose Hypometabolism, and Alzheimer's Disease: A Link to Early Diagnosis and Treatment. J Alzheimers Dis. 2018;63(4):1123-1135. doi: 10.3233/JAD-180091. PMID: 29636652; PMCID: PMC6016147.
* Liang F, Li N, Ma J, Wang F, Huang Y, Yu Q. Dietary patterns and cognitive function among perimenopausal and postmenopausal women: a systematic review and meta-analysis. Front Nutr. 2023 Sep 5;10:1229712. doi: 10.3389/fnut.2023.1229712. PMID: 37720970; PMCID: PMC10505187.
* Bagyinszky E, Giau VV, Youn YC, An SS, Kim S. Insulin resistance in the brain as a link between metabolic and neurodegenerative diseases. Diabetes Metab J. 2018 Oct;42(5):343-352. doi: 10.4093/dmj.2018.0060. Epub 2018 Aug 21. PMID: 30129759; PMCID: PMC6207164.
Q.
The Wrong Type: Why Magnesium Oxide Won't Help You Sleep or Improve Mood
A.
Magnesium oxide is poorly absorbed and mainly works in the gut, so it rarely improves sleep or mood, especially in peri or post menopause; better absorbed options like magnesium glycinate, citrate, taurate, or threonate are typically chosen instead. There are several factors to consider, including other medical causes, medication interactions, safety warnings, and label traps that can change your next steps. See below for specifics on choosing the right form and dose, who should not self treat, and when to speak with a clinician.
References:
* Lindberg, J. S., Zobitz, M. M., Poindexter, J. R., & Pak, C. Y. C. (1990). Magnesium bioavailability from magnesium citrate and magnesium oxide. *Journal of the American College of Nutrition*, *9*(1), 48-55. PMID: 9552199.
* Kukolja, D., Grbas, H., Mihaljević, D., Štimac, D., & Gjurgević-Zorja, A. (2014). Bioavailability of magnesium from magnesium-amino acid chelate and magnesium oxide in healthy adult women. *Collegium Antropologicum*, *38*(3), 1023–1028. PMID: 25178000.
* Ranade, V. V., & Somberg, J. C. (2001). Bioavailability and therapeutic efficacy of magnesium. *Journal of Clinical Pharmacology*, *41*(9), 929-940. PMID: 11570139.
* D'Attilio, M., Di Venere, G., Petrarca, P., Bompani, G., Santini, S., & Calvo, G. (2020). The effect of magnesium on sleep-wakefulness patterns: an overview of animal and human studies. *Nutrients*, *12*(3), 756. PMID: 32204961.
* Sartori, S. B., Whittle, A., Hetzenauer, A., & Singewald, N. (2014). Magnesium in the central nervous system. *Current Neuropharmacology*, *12*(4), 317–328. PMID: 24209587.
Q.
Vasomotor Symptoms: The Physiology of Hot Flashes and Night Sweats
A.
Hot flashes and night sweats happen when estrogen shifts make the brain’s thermostat in the hypothalamus overly sensitive, narrowing the temperature comfort zone and altering serotonin and norepinephrine so small changes trigger rapid skin vasodilation, sweating, palpitations, and sometimes chills afterward. There are several factors to consider, including personal triggers, body composition, medications, sleep impact, how long symptoms last, and red flags like unexplained weight loss, persistent fever, chest pain, fainting, or severe palpitations that need prompt medical care. For treatment options and how to choose next steps, including when lifestyle changes, nonhormonal medicines, or hormone therapy may be appropriate, see the complete answer below.
References:
* Santoro N, Epperson CN, Mathews SB. Menopausal Vasomotor Symptoms: A Review of Epidemiology, Physiology, and Management. Endocr Rev. 2016 Jun;37(3):284-303.
* Rance NE, et al. Biology of Vasomotor Symptoms. Menopause. 2020 Feb;27(2):123-131.
* Thurston RC, Joffe H. Vasomotor symptoms and menopause: current thinking and future directions. Climacteric. 2021 Jun;24(3):214-222.
* Thurston RC, Joffe H, et al. Vasomotor Symptoms and Brain Health in Midlife Women. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2060-e2074.
* Lobo RA, et al. The role of the neurokinin B/NK3 receptor system in the pathophysiology and treatment of hot flashes. Maturitas. 2022 Feb;156:54-61.
Q.
Why Being "Skinny" Is Dangerous: The Risks of Sarcopenic Obesity in Midlife
A.
Being skinny in midlife can be risky because sarcopenic obesity combines low muscle quality with hidden visceral fat, raising the risk of diabetes, heart and liver disease, bone loss, falls, functional decline, and even early mortality despite a normal BMI. There are several factors to consider, including hormonal shifts, inactivity, chronic dieting, and poor sleep, and proven steps like strength training, adequate protein, daily movement, and medical review can improve muscle quality and health; see complete details below to guide the right next steps in your care.
References:
* Kim B, Lee J, Kim H. Sarcopenic Obesity and Metabolic Syndrome: A Narrative Review. J Clin Med. 2022 Jan 3;11(1):219. doi: 10.3390/jcm11010219. PMID: 35011915; PMCID: PMC8746098.
* Gao X, Ding T, Liu H. Sarcopenic obesity: an update on mechanisms and therapeutic strategies. Transl Med Aging. 2022 Nov 4;6:91-99. doi: 10.1016/j.tma.2022.10.003. PMID: 36387063; PMCID: PMC9639556.
* Roh E, Choi KM. Prevalence and consequences of sarcopenic obesity: A systematic review. J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):880-891. doi: 10.1002/jcsm.12239. PMID: 28556428; PMCID: PMC5756303.
* Cruz-Jentoft AJ, Landi F, Perez-Zotano D. Sarcopenic Obesity and Its Association with Cardiometabolic Disorders and Functional Impairment: A Review. Nutrients. 2023 Sep 26;15(19):4124. doi: 10.3390/nu15194124. PMID: 37764835; PMCID: PMC10574189.
* Barazzoni R, Gortan C, Santarossa E, et al. Sarcopenic obesity: the new pandemic? A narrative review of the current evidence on diagnosis, epidemiology, and clinical impact. Obes Rev. 2022 Sep;23 Suppl 2:e13411. doi: 10.1111/obr.13411. Epub 2022 May 4. PMID: 35510617; PMCID: PMC9546087.
Q.
Can menopause cause prolonged heavy bleeding?
A.
Yes, menopause can lead to prolonged heavy bleeding, particularly during the menopausal transition, which is the period leading up to menopause known as perimenopause. This phase is characterized by hormonal fluctuations that can significantly affect menstrual patterns.
References:
Paramsothy P, Harlow SD, Greendale GA, Gold EB, Crawford SL, Elliott MR, Lisabeth LD, Randolph JF Jr. Bleeding patterns during the menopausal transition in the multi-ethnic Study of Women's Health Across the Nation (SWAN): a prospective cohort study. BJOG. 2014 Nov;121(12):1564-73. doi: 10.1111/1471-0528.12768. Epub 2014 Apr 16. PMID: 24735184; PMCID: PMC4199918.
El Khoudary SR, Qi M, Chen X, Matthews K, Allshouse AA, Crawford SL, Derby CA, Thurston RC, Kazlauskaite R, Barinas-Mitchell E, Santoro N. Patterns of menstrual cycle length over the menopause transition are associated with subclinical atherosclerosis after menopause. Menopause. 2021 Oct 11;29(1):8-15. doi: 10.1097/GME.0000000000001876. PMID: 34636354; PMCID: PMC9178927.
Ubie is supervised by 50+ medical experts worldwide
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.
Ubie is recognized by healthcare and tech leaders
“World’s Best Digital
Health Companies”
Newsweek 2024
“Best With AI”
Google Play Best of 2023
“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)
Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1References
Chen LR, Chen KH. Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview. Int J Mol Sci. 2021 Mar 22;22(6):3212. doi: 10.3390/ijms22063212. PMID: 33809928; PMCID: PMC8004126.
https://www.mdpi.com/1422-0067/22/6/3212ACOG Patient FAQ - The Menopause years
https://www.acog.org/womens-health/faqs/the-menopause-yearsThe Menopause Transition: Signs, Symptoms, and Management Options
https://pubmed.ncbi.nlm.nih.gov/33095879/